Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [[maximum depth reached]]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'hindi/news-alerts-57/%E0%A4%B8%E0%A5%81%E0%A4%AA%E0%A5%8D%E0%A4%B0%E0%A5%80%E0%A4%AE-%E0%A4%95%E0%A5%8B%E0%A4%B0%E0%A5%8D%E0%A4%9F-%E0%A4%95%E0%A4%BE-%E0%A4%AB%E0%A5%88%E0%A4%B8%E0%A4%B2%E0%A4%BE-%E0%A4%94%E0%A4%B0-%E0%A4%B8%E0%A4%B8%E0%A5%8D%E0%A4%A4%E0%A5%80-%E0%A4%A6%E0%A4%B5%E0%A4%BE%E0%A4%87%E0%A4%AF%E0%A5%8B%E0%A4%82-%E0%A4%95%E0%A4%BE-%E0%A4%AE%E0%A5%81%E0%A4%A6%E0%A5%8D%E0%A4%A6%E0%A4%BE-5584/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/hindi/news-alerts-57/%E0%A4%B8%E0%A5%81%E0%A4%AA%E0%A5%8D%E0%A4%B0%E0%A5%80%E0%A4%AE-%E0%A4%95%E0%A5%8B%E0%A4%B0%E0%A5%8D%E0%A4%9F-%E0%A4%95%E0%A4%BE-%E0%A4%AB%E0%A5%88%E0%A4%B8%E0%A4%B2%E0%A4%BE-%E0%A4%94%E0%A4%B0-%E0%A4%B8%E0%A4%B8%E0%A5%8D%E0%A4%A4%E0%A5%80-%E0%A4%A6%E0%A4%B5%E0%A4%BE%E0%A4%87%E0%A4%AF%E0%A5%8B%E0%A4%82-%E0%A4%95%E0%A4%BE-%E0%A4%AE%E0%A5%81%E0%A4%A6%E0%A5%8D%E0%A4%A6%E0%A4%BE-5584/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [[maximum depth reached]]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'hindi/news-alerts-57/%E0%A4%B8%E0%A5%81%E0%A4%AA%E0%A5%8D%E0%A4%B0%E0%A5%80%E0%A4%AE-%E0%A4%95%E0%A5%8B%E0%A4%B0%E0%A5%8D%E0%A4%9F-%E0%A4%95%E0%A4%BE-%E0%A4%AB%E0%A5%88%E0%A4%B8%E0%A4%B2%E0%A4%BE-%E0%A4%94%E0%A4%B0-%E0%A4%B8%E0%A4%B8%E0%A5%8D%E0%A4%A4%E0%A5%80-%E0%A4%A6%E0%A4%B5%E0%A4%BE%E0%A4%87%E0%A4%AF%E0%A5%8B%E0%A4%82-%E0%A4%95%E0%A4%BE-%E0%A4%AE%E0%A5%81%E0%A4%A6%E0%A5%8D%E0%A4%A6%E0%A4%BE-5584/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/hindi/news-alerts-57/%E0%A4%B8%E0%A5%81%E0%A4%AA%E0%A5%8D%E0%A4%B0%E0%A5%80%E0%A4%AE-%E0%A4%95%E0%A5%8B%E0%A4%B0%E0%A5%8D%E0%A4%9F-%E0%A4%95%E0%A4%BE-%E0%A4%AB%E0%A5%88%E0%A4%B8%E0%A4%B2%E0%A4%BE-%E0%A4%94%E0%A4%B0-%E0%A4%B8%E0%A4%B8%E0%A5%8D%E0%A4%A4%E0%A5%80-%E0%A4%A6%E0%A4%B5%E0%A4%BE%E0%A4%87%E0%A4%AF%E0%A5%8B%E0%A4%82-%E0%A4%95%E0%A4%BE-%E0%A4%AE%E0%A5%81%E0%A4%A6%E0%A5%8D%E0%A4%A6%E0%A4%BE-5584/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f4edb79e549-trace').style.display = (document.getElementById('cakeErr67f4edb79e549-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f4edb79e549-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f4edb79e549-code').style.display = (document.getElementById('cakeErr67f4edb79e549-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f4edb79e549-context').style.display = (document.getElementById('cakeErr67f4edb79e549-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f4edb79e549-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f4edb79e549-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 46428,
		&#039;title&#039; =&gt; &#039;सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट के फैसले के बाद एक दफे फिर से देश में यह बहस शुरु हो गई है कि सरकारी स्वास्थ्य व्यवस्था लचर है और सरकार की स्वास्थ्य नीति हर जरुरतमंद को कम कीमत में दवा उपलब्ध करा पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
अध्ययनों का निष्कर्ष है कि भारत में स्वास्थ्य के मद में होने वाले खर्च का 70 फीसदी हिस्सा लोगों को अपनी जेब से देना पड़ता है और इस खर्च में दवा की खरीदारी पर 50-80 फीसदी हिस्सा व्यय होता है।&amp;nbsp; ग्रामीण विकास मंत्रालय का तो यह तक कहना है कि ग्रामीण भारतीयों के कर्ज में डूबे होने का सबसे बड़ा कारण बीमारियों के उपचार पर होने वाला खर्च है। &lt;br /&gt;
&lt;br /&gt;
कितनी विडंबनापूर्ण स्थिति है कि एक तरफ मरीज और उसके परिवार-जन को बीमारियों के उपचार का खर्च उठा पाना मुश्किल होता है जबकि दूसरी तरफ यह भी एक तथ्य है कि भारत का 100,000 करोड़ रुपये का दवा-उद्योग अपने आकार में विश्व में तीसरे स्थान पर है और एशिया तथा अफ्रीका के देशों में भारत की दवा-निर्माता कंपनियां सालाना 42000 करोड़ रुपये कीमत की जेनरिक(कम कीमत वाली) दवाइयां बेचती हैं।&lt;br /&gt;
&lt;br /&gt;
सरकार फिलहाल जीडीपी का .1 प्रतिशत(6000 करोड़ रुपये) ही दवाइयों के उपार्जन पर खर्च कर रही है। एक सरकारी रिपोर्ट में तर्क दिया गया है कि इस खर्च को बढाकर जीडीपी का 5 प्रतिशत कर दिया जाय तो &amp;ldquo; सरकारी और निजी अभिकरणों के जरिए सबको जरुरी दवाइयां मुफ्त दी जा सकती हैं।&amp;rdquo; &lt;br /&gt;
&lt;br /&gt;
इसके अतिरिक्त, अध्ययनकर्ताओं का कहना है कि सरकार घरेलू बाजार में दवा की कीमतों और बहुराष्ट्रीय दवा कंपनियों के कामकाज के संचालन के नियमन के लिए पर्याप्त प्रयास नहीं करती। सरकार द्वारा चलायी जा रही जन औषधि योजना के तहत दवा दुकानों से लोगों को उचित मूल्य पर दवा हासिल हो सके- सरकार ऐसा भी कर पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
बारहवीं पंचवर्षीय योजना (2013-17) में सरकारी स्वास्थ्य व्यवस्था को पुनर्जीवित करने की बात कही गई है। बहरहाल देखने वाली बात यह होगी कि क्या नीति-निर्माता लोगों की खरीद की पहुंच से बाहर जाती दवाइयों को किस हद तक उनकी पहुंच के दायरे में ला पाते हैं।&amp;nbsp;&amp;nbsp; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
इस कथा का विस्तार निम्नलिखित लिंक्स के सहारे किया जा सकता है- 
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Basic backgrounders on generics and why they are lesser
priced&lt;br /&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot;&gt;http://health.india.com/diseases-conditions/generic-drugs-what-yo&lt;br /&gt;
u-need-to-know/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot;&gt;http://www.who.int/trade/glossary/story034/en/&lt;/a&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Findings and recommendations by the government&amp;rsquo;s High Level
Expert Group (HLEG) on Universal Health Coverage (UHC), which submitted its
report in October 2010&lt;br /&gt;
&lt;a href=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot;&gt;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A report on meeting the challenges facing Indian pharma:&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot;&gt;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_ph&lt;br /&gt;
arma2902.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
The National Pharmaceutical Pricing Policy (NPPP-2012) which
was notified in November 2012 and seeks to regulate prices of 348 essential
medicines, and the Jan Aushadhi scheme for a network of public fair-price
medicine shops:
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot;&gt;www.nppaindia.nic.in&lt;/a&gt; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot;&gt;www.janaushadhi.gov.in&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Low-cost Jan Aushadhi stores to be re-invented, The Hindu
Business Line, July 27 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot;&gt;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadh&lt;br /&gt;
i-stores-to-be-reinvented/article3693097.ece&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;The implications of a failing public healthcare system for rural
Indians:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Public health system in India has collapsed: Ramesh, The
Hindu, 16 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot;&gt;http://www.thehindu.com/news/national/public-health-system-in-ind&lt;br /&gt;
ia-has-collapsed-ramesh/article4101836.ece &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Free drugs for all?-Nirmalya Dutta, 30 November, 2012,&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot;&gt;http://health.india.com/diseases-conditions/independence-day-2012&lt;br /&gt;
-free-drugs-for-all/&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
A paper exploring the links between rural indebtedness and healthcare costs in
Gurdaspur and Amritsar districts of Punjab&lt;br /&gt;
&lt;a href=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot;&gt;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-pu&lt;br /&gt;
njab.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;Initiatives by state governments in Rajasthan and West Bengal to
provide access to affordable generic drugs:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Mamata Banerjee battles for generic drugs, 16 March, 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot;&gt;http://health.india.com/diseases-conditions/mamata-banerjee-battl&lt;br /&gt;
es-for-generic-drugs/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
India Poised to Supply Free
Drugs to 1.2 Billion People-Zofeen Ebrahim, 8 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot;&gt;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-&lt;br /&gt;
to-1-2-billion-people/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
There Is A
cure -Pragya Singh, Outlook, 27 July, 2009 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot;&gt;http://www.outlookindia.com/article.aspx?250525&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A field report on how the National Health Insurance system is working:&lt;br /&gt;
&lt;a href=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot;&gt;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Indian patent rulings may face legal heat internationally
-Soma Das &lt;br /&gt;
The Economic Times, 11 April, 2013, &lt;a href=&quot;../latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot;&gt;http://www.im4change.org/latest-news-updates/indian-patent-ruling&lt;br /&gt;
s-may-face-legal-heat-internationally-soma-das-20409.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
HIV, cancer patients seek access to affordable medicines-Aarti Dhar, &lt;br /&gt;
&lt;a href=&quot;../latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot;&gt;The
Hindu, 11 April, 2013, http://www.im4change.org/latest-news-u&lt;br /&gt;
pdates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Natco Pharma wins cancer drug case-R Sivaraman, The Hindu, 4
March, 2013, &lt;a href=&quot;../latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot;&gt;http://www.im4change.org/latest-news-updates/natco-pharma-wins-ca&lt;br /&gt;
ncer-drug-case-r-sivaraman-19744.html &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
EU, Australia, Canada may follow India&amp;rsquo;s Patent Law -Divya
Rajagopal, The Economic Times, 4 April, 2013, &lt;a href=&quot;../latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot;&gt;http://www.im4change.org/latest-news-updates/eu-australia-canada-&lt;br /&gt;
may-follow-indias-patent-law-divya-rajagopal-20307.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
When innovation is under threat-Swati Piramal, The Indian
Express, 2 April, 2013, &lt;a href=&quot;../latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot;&gt;http://www.im4change.org/latest-news-updates/when-innovation-is-u&lt;br /&gt;
nder-threat-swati-piramal-20286.html&lt;/a&gt;&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
YK Sapru, founder chairperson of Cancer Patients Aid Association
(CPAA) interviewed by Sushmi Dey, The Business Standard, 3 April, 2013, &lt;a href=&quot;../interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot;&gt;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-&lt;br /&gt;
of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;Novartis
patent case: Glivec developer Brian Druker hails SC ruling- Chidanand
Rajghatta, The Economic Times, 3 April, 2013, &lt;a href=&quot;../latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;http://www.im4change.org/latest-news-updates/novartis-patent-case&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;&lt;a href=&quot;../latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
(एलर्ट में इस्तेमाल किए गए चित्र के लिए हम http://www.unn-edu.net/wp-content/uploads/2010/02/Medicine.jpg के आभारी हैं) &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;H&#039;,
		&#039;category_id&#039; =&gt; (int) 70,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;सुप्रीम-कोर्ट-का-फैसला-और-सस्ती-दवाइयों-का-मुद्दा-5584&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 5584,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 46428,
	&#039;metaTitle&#039; =&gt; &#039;चर्चा में.... | सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;स्वास्थ्य,सेहत,स्वास्थ्य,सेहत&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट के फैसले के बाद एक दफे फिर से देश में यह बहस शुरु हो गई है कि सरकारी स्वास्थ्य व्यवस्था लचर है और सरकार की स्वास्थ्य नीति हर जरुरतमंद को कम कीमत में दवा उपलब्ध करा पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
अध्ययनों का निष्कर्ष है कि भारत में स्वास्थ्य के मद में होने वाले खर्च का 70 फीसदी हिस्सा लोगों को अपनी जेब से देना पड़ता है और इस खर्च में दवा की खरीदारी पर 50-80 फीसदी हिस्सा व्यय होता है।&amp;nbsp; ग्रामीण विकास मंत्रालय का तो यह तक कहना है कि ग्रामीण भारतीयों के कर्ज में डूबे होने का सबसे बड़ा कारण बीमारियों के उपचार पर होने वाला खर्च है। &lt;br /&gt;
&lt;br /&gt;
कितनी विडंबनापूर्ण स्थिति है कि एक तरफ मरीज और उसके परिवार-जन को बीमारियों के उपचार का खर्च उठा पाना मुश्किल होता है जबकि दूसरी तरफ यह भी एक तथ्य है कि भारत का 100,000 करोड़ रुपये का दवा-उद्योग अपने आकार में विश्व में तीसरे स्थान पर है और एशिया तथा अफ्रीका के देशों में भारत की दवा-निर्माता कंपनियां सालाना 42000 करोड़ रुपये कीमत की जेनरिक(कम कीमत वाली) दवाइयां बेचती हैं।&lt;br /&gt;
&lt;br /&gt;
सरकार फिलहाल जीडीपी का .1 प्रतिशत(6000 करोड़ रुपये) ही दवाइयों के उपार्जन पर खर्च कर रही है। एक सरकारी रिपोर्ट में तर्क दिया गया है कि इस खर्च को बढाकर जीडीपी का 5 प्रतिशत कर दिया जाय तो &amp;ldquo; सरकारी और निजी अभिकरणों के जरिए सबको जरुरी दवाइयां मुफ्त दी जा सकती हैं।&amp;rdquo; &lt;br /&gt;
&lt;br /&gt;
इसके अतिरिक्त, अध्ययनकर्ताओं का कहना है कि सरकार घरेलू बाजार में दवा की कीमतों और बहुराष्ट्रीय दवा कंपनियों के कामकाज के संचालन के नियमन के लिए पर्याप्त प्रयास नहीं करती। सरकार द्वारा चलायी जा रही जन औषधि योजना के तहत दवा दुकानों से लोगों को उचित मूल्य पर दवा हासिल हो सके- सरकार ऐसा भी कर पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
बारहवीं पंचवर्षीय योजना (2013-17) में सरकारी स्वास्थ्य व्यवस्था को पुनर्जीवित करने की बात कही गई है। बहरहाल देखने वाली बात यह होगी कि क्या नीति-निर्माता लोगों की खरीद की पहुंच से बाहर जाती दवाइयों को किस हद तक उनकी पहुंच के दायरे में ला पाते हैं।&amp;nbsp;&amp;nbsp; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
इस कथा का विस्तार निम्नलिखित लिंक्स के सहारे किया जा सकता है- 
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Basic backgrounders on generics and why they are lesser
priced&lt;br /&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot;&gt;http://health.india.com/diseases-conditions/generic-drugs-&lt;br /&gt;what-yo
u-need-to-know/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot;&gt;http://www.who.int/trade/glossary/story034/en/&lt;/a&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Findings and recommendations by the government&amp;rsquo;s High Level
Expert Group (HLEG) on Universal Health Coverage (UHC), which submitted its
report in October 2010&lt;br /&gt;
&lt;a href=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot;&gt;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A report on meeting the challenges facing Indian pharma:&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot;&gt;http://planningcommission.nic.in/aboutus/committee/wrkgrp1&lt;br /&gt;2/wg_ph
arma2902.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
The National Pharmaceutical Pricing Policy (NPPP-2012) which
was notified in November 2012 and seeks to regulate prices of 348 essential
medicines, and the Jan Aushadhi scheme for a network of public fair-price
medicine shops:
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot;&gt;www.nppaindia.nic.in&lt;/a&gt; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot;&gt;www.janaushadhi.gov.in&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Low-cost Jan Aushadhi stores to be re-invented, The Hindu
Business Line, July 27 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot;&gt;http://www.thehindubusinessline.com/marketing/lowcost-jan-&lt;br /&gt;aushadh
i-stores-to-be-reinvented/article3693097.ece&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;The implications of a failing public healthcare system for rural
Indians:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Public health system in India has collapsed: Ramesh, The
Hindu, 16 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot;&gt;http://www.thehindu.com/news/national/public-health-system&lt;br /&gt;-in-ind
ia-has-collapsed-ramesh/article4101836.ece &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Free drugs for all?-Nirmalya Dutta, 30 November, 2012,&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot;&gt;http://health.india.com/diseases-conditions/independence-d&lt;br /&gt;ay-2012
-free-drugs-for-all/&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
A paper exploring the links between rural indebtedness and healthcare costs in
Gurdaspur and Amritsar districts of Punjab&lt;br /&gt;
&lt;a href=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot;&gt;http://www.epw.in/commentary/rural-healthcare-and-indebted&lt;br /&gt;ness-pu
njab.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;Initiatives by state governments in Rajasthan and West Bengal to
provide access to affordable generic drugs:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Mamata Banerjee battles for generic drugs, 16 March, 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot;&gt;http://health.india.com/diseases-conditions/mamata-banerje&lt;br /&gt;e-battl
es-for-generic-drugs/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
India Poised to Supply Free
Drugs to 1.2 Billion People-Zofeen Ebrahim, 8 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot;&gt;http://www.ipsnews.net/2012/11/india-poised-to-supply-free&lt;br /&gt;-drugs-
to-1-2-billion-people/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
There Is A
cure -Pragya Singh, Outlook, 27 July, 2009 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot;&gt;http://www.outlookindia.com/article.aspx?250525&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A field report on how the National Health Insurance system is working:&lt;br /&gt;
&lt;a href=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot;&gt;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Indian patent rulings may face legal heat internationally
-Soma Das &lt;br /&gt;
The Economic Times, 11 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot;&gt;http://www.im4change.org/latest-news-updates/indian-patent&lt;br /&gt;-ruling
s-may-face-legal-heat-internationally-soma-das-20&lt;br /&gt;409.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
HIV, cancer patients seek access to affordable medicines-Aarti Dhar, &lt;br /&gt;
&lt;a href=&quot;https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot;&gt;The
Hindu, 11 April, 2013, http://www.im4change.org/lates&lt;br /&gt;t-news-u
pdates/hiv-cancer-patients-seek-access-to-afford&lt;br /&gt;able-medicines-aarti-dhar-20403.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Natco Pharma wins cancer drug case-R Sivaraman, The Hindu, 4
March, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot;&gt;http://www.im4change.org/latest-news-updates/natco-pharma-&lt;br /&gt;wins-ca
ncer-drug-case-r-sivaraman-19744.html &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
EU, Australia, Canada may follow India&amp;rsquo;s Patent Law -Divya
Rajagopal, The Economic Times, 4 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot;&gt;http://www.im4change.org/latest-news-updates/eu-australia-&lt;br /&gt;canada-
may-follow-indias-patent-law-divya-rajagopal-2030&lt;br /&gt;7.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
When innovation is under threat-Swati Piramal, The Indian
Express, 2 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot;&gt;http://www.im4change.org/latest-news-updates/when-innovati&lt;br /&gt;on-is-u
nder-threat-swati-piramal-20286.html&lt;/a&gt;&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
YK Sapru, founder chairperson of Cancer Patients Aid Association
(CPAA) interviewed by Sushmi Dey, The Business Standard, 3 April, 2013, &lt;a href=&quot;https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot;&gt;http://www.im4change.org/interviews/yk-sapru-founder-chair&lt;br /&gt;person-
of-cancer-patients-aid-association-cpaa-interview&lt;br /&gt;ed-by-sushmi-dey-20267.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;Novartis
patent case: Glivec developer Brian Druker hails SC ruling- Chidanand
Rajghatta, The Economic Times, 3 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;http://www.im4change.org/latest-news-updates/novartis-patent-case&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;&lt;a href=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;-glivec-developer-brian-druker-hails-sc-ruling-chidanand-r&lt;br /&gt;ajghatta-20265.html&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
(एलर्ट में इस्तेमाल किए गए चित्र के लिए हम http://www.unn-edu.net/wp-content/uploads/2010/02/Medicine.jpg के आभारी हैं) &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;Hindi&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 46428,
	&#039;title&#039; =&gt; &#039;सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट के फैसले के बाद एक दफे फिर से देश में यह बहस शुरु हो गई है कि सरकारी स्वास्थ्य व्यवस्था लचर है और सरकार की स्वास्थ्य नीति हर जरुरतमंद को कम कीमत में दवा उपलब्ध करा पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
अध्ययनों का निष्कर्ष है कि भारत में स्वास्थ्य के मद में होने वाले खर्च का 70 फीसदी हिस्सा लोगों को अपनी जेब से देना पड़ता है और इस खर्च में दवा की खरीदारी पर 50-80 फीसदी हिस्सा व्यय होता है।&amp;nbsp; ग्रामीण विकास मंत्रालय का तो यह तक कहना है कि ग्रामीण भारतीयों के कर्ज में डूबे होने का सबसे बड़ा कारण बीमारियों के उपचार पर होने वाला खर्च है। &lt;br /&gt;
&lt;br /&gt;
कितनी विडंबनापूर्ण स्थिति है कि एक तरफ मरीज और उसके परिवार-जन को बीमारियों के उपचार का खर्च उठा पाना मुश्किल होता है जबकि दूसरी तरफ यह भी एक तथ्य है कि भारत का 100,000 करोड़ रुपये का दवा-उद्योग अपने आकार में विश्व में तीसरे स्थान पर है और एशिया तथा अफ्रीका के देशों में भारत की दवा-निर्माता कंपनियां सालाना 42000 करोड़ रुपये कीमत की जेनरिक(कम कीमत वाली) दवाइयां बेचती हैं।&lt;br /&gt;
&lt;br /&gt;
सरकार फिलहाल जीडीपी का .1 प्रतिशत(6000 करोड़ रुपये) ही दवाइयों के उपार्जन पर खर्च कर रही है। एक सरकारी रिपोर्ट में तर्क दिया गया है कि इस खर्च को बढाकर जीडीपी का 5 प्रतिशत कर दिया जाय तो &amp;ldquo; सरकारी और निजी अभिकरणों के जरिए सबको जरुरी दवाइयां मुफ्त दी जा सकती हैं।&amp;rdquo; &lt;br /&gt;
&lt;br /&gt;
इसके अतिरिक्त, अध्ययनकर्ताओं का कहना है कि सरकार घरेलू बाजार में दवा की कीमतों और बहुराष्ट्रीय दवा कंपनियों के कामकाज के संचालन के नियमन के लिए पर्याप्त प्रयास नहीं करती। सरकार द्वारा चलायी जा रही जन औषधि योजना के तहत दवा दुकानों से लोगों को उचित मूल्य पर दवा हासिल हो सके- सरकार ऐसा भी कर पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
बारहवीं पंचवर्षीय योजना (2013-17) में सरकारी स्वास्थ्य व्यवस्था को पुनर्जीवित करने की बात कही गई है। बहरहाल देखने वाली बात यह होगी कि क्या नीति-निर्माता लोगों की खरीद की पहुंच से बाहर जाती दवाइयों को किस हद तक उनकी पहुंच के दायरे में ला पाते हैं।&amp;nbsp;&amp;nbsp; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
इस कथा का विस्तार निम्नलिखित लिंक्स के सहारे किया जा सकता है- 
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Basic backgrounders on generics and why they are lesser
priced&lt;br /&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot;&gt;http://health.india.com/diseases-conditions/generic-drugs-what-yo&lt;br /&gt;
u-need-to-know/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot;&gt;http://www.who.int/trade/glossary/story034/en/&lt;/a&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Findings and recommendations by the government&amp;rsquo;s High Level
Expert Group (HLEG) on Universal Health Coverage (UHC), which submitted its
report in October 2010&lt;br /&gt;
&lt;a href=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot;&gt;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A report on meeting the challenges facing Indian pharma:&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot;&gt;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_ph&lt;br /&gt;
arma2902.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
The National Pharmaceutical Pricing Policy (NPPP-2012) which
was notified in November 2012 and seeks to regulate prices of 348 essential
medicines, and the Jan Aushadhi scheme for a network of public fair-price
medicine shops:
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot;&gt;www.nppaindia.nic.in&lt;/a&gt; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot;&gt;www.janaushadhi.gov.in&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Low-cost Jan Aushadhi stores to be re-invented, The Hindu
Business Line, July 27 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot;&gt;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadh&lt;br /&gt;
i-stores-to-be-reinvented/article3693097.ece&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;The implications of a failing public healthcare system for rural
Indians:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Public health system in India has collapsed: Ramesh, The
Hindu, 16 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot;&gt;http://www.thehindu.com/news/national/public-health-system-in-ind&lt;br /&gt;
ia-has-collapsed-ramesh/article4101836.ece &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Free drugs for all?-Nirmalya Dutta, 30 November, 2012,&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot;&gt;http://health.india.com/diseases-conditions/independence-day-2012&lt;br /&gt;
-free-drugs-for-all/&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
A paper exploring the links between rural indebtedness and healthcare costs in
Gurdaspur and Amritsar districts of Punjab&lt;br /&gt;
&lt;a href=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot;&gt;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-pu&lt;br /&gt;
njab.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;Initiatives by state governments in Rajasthan and West Bengal to
provide access to affordable generic drugs:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Mamata Banerjee battles for generic drugs, 16 March, 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot;&gt;http://health.india.com/diseases-conditions/mamata-banerjee-battl&lt;br /&gt;
es-for-generic-drugs/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
India Poised to Supply Free
Drugs to 1.2 Billion People-Zofeen Ebrahim, 8 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot;&gt;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-&lt;br /&gt;
to-1-2-billion-people/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
There Is A
cure -Pragya Singh, Outlook, 27 July, 2009 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot;&gt;http://www.outlookindia.com/article.aspx?250525&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A field report on how the National Health Insurance system is working:&lt;br /&gt;
&lt;a href=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot;&gt;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Indian patent rulings may face legal heat internationally
-Soma Das &lt;br /&gt;
The Economic Times, 11 April, 2013, &lt;a href=&quot;../latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot;&gt;http://www.im4change.org/latest-news-updates/indian-patent-ruling&lt;br /&gt;
s-may-face-legal-heat-internationally-soma-das-20409.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
HIV, cancer patients seek access to affordable medicines-Aarti Dhar, &lt;br /&gt;
&lt;a href=&quot;../latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot;&gt;The
Hindu, 11 April, 2013, http://www.im4change.org/latest-news-u&lt;br /&gt;
pdates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Natco Pharma wins cancer drug case-R Sivaraman, The Hindu, 4
March, 2013, &lt;a href=&quot;../latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot;&gt;http://www.im4change.org/latest-news-updates/natco-pharma-wins-ca&lt;br /&gt;
ncer-drug-case-r-sivaraman-19744.html &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
EU, Australia, Canada may follow India&amp;rsquo;s Patent Law -Divya
Rajagopal, The Economic Times, 4 April, 2013, &lt;a href=&quot;../latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot;&gt;http://www.im4change.org/latest-news-updates/eu-australia-canada-&lt;br /&gt;
may-follow-indias-patent-law-divya-rajagopal-20307.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
When innovation is under threat-Swati Piramal, The Indian
Express, 2 April, 2013, &lt;a href=&quot;../latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot;&gt;http://www.im4change.org/latest-news-updates/when-innovation-is-u&lt;br /&gt;
nder-threat-swati-piramal-20286.html&lt;/a&gt;&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
YK Sapru, founder chairperson of Cancer Patients Aid Association
(CPAA) interviewed by Sushmi Dey, The Business Standard, 3 April, 2013, &lt;a href=&quot;../interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot;&gt;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-&lt;br /&gt;
of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;Novartis
patent case: Glivec developer Brian Druker hails SC ruling- Chidanand
Rajghatta, The Economic Times, 3 April, 2013, &lt;a href=&quot;../latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;http://www.im4change.org/latest-news-updates/novartis-patent-case&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;&lt;a href=&quot;../latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
(एलर्ट में इस्तेमाल किए गए चित्र के लिए हम http://www.unn-edu.net/wp-content/uploads/2010/02/Medicine.jpg के आभारी हैं) &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;H&#039;,
	&#039;category_id&#039; =&gt; (int) 70,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;सुप्रीम-कोर्ट-का-फैसला-और-सस्ती-दवाइयों-का-मुद्दा-5584&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 5584,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 46428
$metaTitle = &#039;चर्चा में.... | सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा&#039;
$metaKeywords = &#039;स्वास्थ्य,सेहत,स्वास्थ्य,सेहत&#039;
$metaDesc = &#039;
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट के फैसले के बाद एक दफे फिर से देश में यह बहस शुरु हो गई है कि सरकारी स्वास्थ्य व्यवस्था लचर है और सरकार की स्वास्थ्य नीति हर जरुरतमंद को कम कीमत में दवा उपलब्ध करा पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
अध्ययनों का निष्कर्ष है कि भारत में स्वास्थ्य के मद में होने वाले खर्च का 70 फीसदी हिस्सा लोगों को अपनी जेब से देना पड़ता है और इस खर्च में दवा की खरीदारी पर 50-80 फीसदी हिस्सा व्यय होता है।&amp;nbsp; ग्रामीण विकास मंत्रालय का तो यह तक कहना है कि ग्रामीण भारतीयों के कर्ज में डूबे होने का सबसे बड़ा कारण बीमारियों के उपचार पर होने वाला खर्च है। &lt;br /&gt;
&lt;br /&gt;
कितनी विडंबनापूर्ण स्थिति है कि एक तरफ मरीज और उसके परिवार-जन को बीमारियों के उपचार का खर्च उठा पाना मुश्किल होता है जबकि दूसरी तरफ यह भी एक तथ्य है कि भारत का 100,000 करोड़ रुपये का दवा-उद्योग अपने आकार में विश्व में तीसरे स्थान पर है और एशिया तथा अफ्रीका के देशों में भारत की दवा-निर्माता कंपनियां सालाना 42000 करोड़ रुपये कीमत की जेनरिक(कम कीमत वाली) दवाइयां बेचती हैं।&lt;br /&gt;
&lt;br /&gt;
सरकार फिलहाल जीडीपी का .1 प्रतिशत(6000 करोड़ रुपये) ही दवाइयों के उपार्जन पर खर्च कर रही है। एक सरकारी रिपोर्ट में तर्क दिया गया है कि इस खर्च को बढाकर जीडीपी का 5 प्रतिशत कर दिया जाय तो &amp;ldquo; सरकारी और निजी अभिकरणों के जरिए सबको जरुरी दवाइयां मुफ्त दी जा सकती हैं।&amp;rdquo; &lt;br /&gt;
&lt;br /&gt;
इसके अतिरिक्त, अध्ययनकर्ताओं का कहना है कि सरकार घरेलू बाजार में दवा की कीमतों और बहुराष्ट्रीय दवा कंपनियों के कामकाज के संचालन के नियमन के लिए पर्याप्त प्रयास नहीं करती। सरकार द्वारा चलायी जा रही जन औषधि योजना के तहत दवा दुकानों से लोगों को उचित मूल्य पर दवा हासिल हो सके- सरकार ऐसा भी कर पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
बारहवीं पंचवर्षीय योजना (2013-17) में सरकारी स्वास्थ्य व्यवस्था को पुनर्जीवित करने की बात कही गई है। बहरहाल देखने वाली बात यह होगी कि क्या नीति-निर्माता लोगों की खरीद की पहुंच से बाहर जाती दवाइयों को किस हद तक उनकी पहुंच के दायरे में ला पाते हैं।&amp;nbsp;&amp;nbsp; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
इस कथा का विस्तार निम्नलिखित लिंक्स के सहारे किया जा सकता है- 
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Basic backgrounders on generics and why they are lesser
priced&lt;br /&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot;&gt;http://health.india.com/diseases-conditions/generic-drugs-&lt;br /&gt;what-yo
u-need-to-know/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot;&gt;http://www.who.int/trade/glossary/story034/en/&lt;/a&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Findings and recommendations by the government&amp;rsquo;s High Level
Expert Group (HLEG) on Universal Health Coverage (UHC), which submitted its
report in October 2010&lt;br /&gt;
&lt;a href=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot;&gt;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A report on meeting the challenges facing Indian pharma:&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot;&gt;http://planningcommission.nic.in/aboutus/committee/wrkgrp1&lt;br /&gt;2/wg_ph
arma2902.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
The National Pharmaceutical Pricing Policy (NPPP-2012) which
was notified in November 2012 and seeks to regulate prices of 348 essential
medicines, and the Jan Aushadhi scheme for a network of public fair-price
medicine shops:
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot;&gt;www.nppaindia.nic.in&lt;/a&gt; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot;&gt;www.janaushadhi.gov.in&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Low-cost Jan Aushadhi stores to be re-invented, The Hindu
Business Line, July 27 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot;&gt;http://www.thehindubusinessline.com/marketing/lowcost-jan-&lt;br /&gt;aushadh
i-stores-to-be-reinvented/article3693097.ece&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;The implications of a failing public healthcare system for rural
Indians:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Public health system in India has collapsed: Ramesh, The
Hindu, 16 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot;&gt;http://www.thehindu.com/news/national/public-health-system&lt;br /&gt;-in-ind
ia-has-collapsed-ramesh/article4101836.ece &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Free drugs for all?-Nirmalya Dutta, 30 November, 2012,&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot;&gt;http://health.india.com/diseases-conditions/independence-d&lt;br /&gt;ay-2012
-free-drugs-for-all/&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
A paper exploring the links between rural indebtedness and healthcare costs in
Gurdaspur and Amritsar districts of Punjab&lt;br /&gt;
&lt;a href=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot;&gt;http://www.epw.in/commentary/rural-healthcare-and-indebted&lt;br /&gt;ness-pu
njab.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;Initiatives by state governments in Rajasthan and West Bengal to
provide access to affordable generic drugs:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Mamata Banerjee battles for generic drugs, 16 March, 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot;&gt;http://health.india.com/diseases-conditions/mamata-banerje&lt;br /&gt;e-battl
es-for-generic-drugs/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
India Poised to Supply Free
Drugs to 1.2 Billion People-Zofeen Ebrahim, 8 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot;&gt;http://www.ipsnews.net/2012/11/india-poised-to-supply-free&lt;br /&gt;-drugs-
to-1-2-billion-people/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
There Is A
cure -Pragya Singh, Outlook, 27 July, 2009 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot;&gt;http://www.outlookindia.com/article.aspx?250525&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A field report on how the National Health Insurance system is working:&lt;br /&gt;
&lt;a href=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot;&gt;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Indian patent rulings may face legal heat internationally
-Soma Das &lt;br /&gt;
The Economic Times, 11 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot;&gt;http://www.im4change.org/latest-news-updates/indian-patent&lt;br /&gt;-ruling
s-may-face-legal-heat-internationally-soma-das-20&lt;br /&gt;409.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
HIV, cancer patients seek access to affordable medicines-Aarti Dhar, &lt;br /&gt;
&lt;a href=&quot;https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot;&gt;The
Hindu, 11 April, 2013, http://www.im4change.org/lates&lt;br /&gt;t-news-u
pdates/hiv-cancer-patients-seek-access-to-afford&lt;br /&gt;able-medicines-aarti-dhar-20403.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Natco Pharma wins cancer drug case-R Sivaraman, The Hindu, 4
March, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot;&gt;http://www.im4change.org/latest-news-updates/natco-pharma-&lt;br /&gt;wins-ca
ncer-drug-case-r-sivaraman-19744.html &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
EU, Australia, Canada may follow India&amp;rsquo;s Patent Law -Divya
Rajagopal, The Economic Times, 4 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot;&gt;http://www.im4change.org/latest-news-updates/eu-australia-&lt;br /&gt;canada-
may-follow-indias-patent-law-divya-rajagopal-2030&lt;br /&gt;7.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
When innovation is under threat-Swati Piramal, The Indian
Express, 2 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot;&gt;http://www.im4change.org/latest-news-updates/when-innovati&lt;br /&gt;on-is-u
nder-threat-swati-piramal-20286.html&lt;/a&gt;&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
YK Sapru, founder chairperson of Cancer Patients Aid Association
(CPAA) interviewed by Sushmi Dey, The Business Standard, 3 April, 2013, &lt;a href=&quot;https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot;&gt;http://www.im4change.org/interviews/yk-sapru-founder-chair&lt;br /&gt;person-
of-cancer-patients-aid-association-cpaa-interview&lt;br /&gt;ed-by-sushmi-dey-20267.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;Novartis
patent case: Glivec developer Brian Druker hails SC ruling- Chidanand
Rajghatta, The Economic Times, 3 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;http://www.im4change.org/latest-news-updates/novartis-patent-case&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;&lt;a href=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;-glivec-developer-brian-druker-hails-sc-ruling-chidanand-r&lt;br /&gt;ajghatta-20265.html&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
(एलर्ट में इस्तेमाल किए गए चित्र के लिए हम http://www.unn-edu.net/wp-content/uploads/2010/02/Medicine.jpg के आभारी हैं) &lt;br /&gt;
&lt;/div&gt;&#039;
$lang = &#039;Hindi&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>news-alerts-57/सुप्रीम-कोर्ट-का-फैसला-और-सस्ती-दवाइयों-का-मुद्दा-5584.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>चर्चा में.... | सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा | Im4change.org</title>
    <meta name="description" content="
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट के फैसले के बाद एक दफे फिर से देश में यह बहस शुरु हो गई है कि सरकारी स्वास्थ्य व्यवस्था लचर है और सरकार की स्वास्थ्य नीति हर जरुरतमंद को कम कीमत में दवा उपलब्ध करा पाने में नाकाम रही है। <br />
<br />
अध्ययनों का निष्कर्ष है कि भारत में स्वास्थ्य के मद में होने वाले खर्च का 70 फीसदी हिस्सा लोगों को अपनी जेब से देना पड़ता है और इस खर्च में दवा की खरीदारी पर 50-80 फीसदी हिस्सा व्यय होता है।&nbsp; ग्रामीण विकास मंत्रालय का तो यह तक कहना है कि ग्रामीण भारतीयों के कर्ज में डूबे होने का सबसे बड़ा कारण बीमारियों के उपचार पर होने वाला खर्च है। <br />
<br />
कितनी विडंबनापूर्ण स्थिति है कि एक तरफ मरीज और उसके परिवार-जन को बीमारियों के उपचार का खर्च उठा पाना मुश्किल होता है जबकि दूसरी तरफ यह भी एक तथ्य है कि भारत का 100,000 करोड़ रुपये का दवा-उद्योग अपने आकार में विश्व में तीसरे स्थान पर है और एशिया तथा अफ्रीका के देशों में भारत की दवा-निर्माता कंपनियां सालाना 42000 करोड़ रुपये कीमत की जेनरिक(कम कीमत वाली) दवाइयां बेचती हैं।<br />
<br />
सरकार फिलहाल जीडीपी का .1 प्रतिशत(6000 करोड़ रुपये) ही दवाइयों के उपार्जन पर खर्च कर रही है। एक सरकारी रिपोर्ट में तर्क दिया गया है कि इस खर्च को बढाकर जीडीपी का 5 प्रतिशत कर दिया जाय तो &ldquo; सरकारी और निजी अभिकरणों के जरिए सबको जरुरी दवाइयां मुफ्त दी जा सकती हैं।&rdquo; <br />
<br />
इसके अतिरिक्त, अध्ययनकर्ताओं का कहना है कि सरकार घरेलू बाजार में दवा की कीमतों और बहुराष्ट्रीय दवा कंपनियों के कामकाज के संचालन के नियमन के लिए पर्याप्त प्रयास नहीं करती। सरकार द्वारा चलायी जा रही जन औषधि योजना के तहत दवा दुकानों से लोगों को उचित मूल्य पर दवा हासिल हो सके- सरकार ऐसा भी कर पाने में नाकाम रही है। <br />
<br />
बारहवीं पंचवर्षीय योजना (2013-17) में सरकारी स्वास्थ्य व्यवस्था को पुनर्जीवित करने की बात कही गई है। बहरहाल देखने वाली बात यह होगी कि क्या नीति-निर्माता लोगों की खरीद की पहुंच से बाहर जाती दवाइयों को किस हद तक उनकी पहुंच के दायरे में ला पाते हैं।&nbsp;&nbsp; &nbsp;<br />
<br />
इस कथा का विस्तार निम्नलिखित लिंक्स के सहारे किया जा सकता है- 
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
<p class="MsoNormal">
Basic backgrounders on generics and why they are lesser
priced<br />
<a href="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/" title="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/" title="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/" title="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/">http://health.india.com/diseases-conditions/generic-drugs-<br />what-yo
u-need-to-know/</a>
</p>
<p class="MsoNormal">
<a href="http://www.who.int/trade/glossary/story034/en/" title="http://www.who.int/trade/glossary/story034/en/" title="http://www.who.int/trade/glossary/story034/en/" title="http://www.who.int/trade/glossary/story034/en/">http://www.who.int/trade/glossary/story034/en/</a>
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Findings and recommendations by the government&rsquo;s High Level
Expert Group (HLEG) on Universal Health Coverage (UHC), which submitted its
report in October 2010<br />
<a href="http://uhc-india.org/reports/hleg_report_chapter_3.pdf" title="http://uhc-india.org/reports/hleg_report_chapter_3.pdf" title="http://uhc-india.org/reports/hleg_report_chapter_3.pdf" title="http://uhc-india.org/reports/hleg_report_chapter_3.pdf">http://uhc-india.org/reports/hleg_report_chapter_3.pdf</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
<br />
A report on meeting the challenges facing Indian pharma:&nbsp; 
</p>
<p class="MsoNormal">
<a href="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf" title="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf" title="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf" title="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf">http://planningcommission.nic.in/aboutus/committee/wrkgrp1<br />2/wg_ph
arma2902.pdf</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
The National Pharmaceutical Pricing Policy (NPPP-2012) which
was notified in November 2012 and seeks to regulate prices of 348 essential
medicines, and the Jan Aushadhi scheme for a network of public fair-price
medicine shops:
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
<a href="http://www.nppaindia.nic.in" title="http://www.nppaindia.nic.in" title="http://www.nppaindia.nic.in" title="http://www.nppaindia.nic.in">www.nppaindia.nic.in</a> &nbsp;<br />
<br />
<a href="http://www.janaushadhi.gov.in" title="http://www.janaushadhi.gov.in" title="http://www.janaushadhi.gov.in" title="http://www.janaushadhi.gov.in">www.janaushadhi.gov.in</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Low-cost Jan Aushadhi stores to be re-invented, The Hindu
Business Line, July 27 2012 
</p>
<p class="MsoNormal">
<a href="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece" title="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece" title="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece" title="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece">http://www.thehindubusinessline.com/marketing/lowcost-jan-<br />aushadh
i-stores-to-be-reinvented/article3693097.ece</a><br />
<br />
<em><span>The implications of a failing public healthcare system for rural
Indians:</span></em>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Public health system in India has collapsed: Ramesh, The
Hindu, 16 November, 2012<br />
<a href="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece" title="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece" title="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece" title="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece">http://www.thehindu.com/news/national/public-health-system<br />-in-ind
ia-has-collapsed-ramesh/article4101836.ece </a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Free drugs for all?-Nirmalya Dutta, 30 November, 2012,&nbsp;
</p>
<p class="MsoNormal">
<a href="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/" title="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/" title="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/" title="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/">http://health.india.com/diseases-conditions/independence-d<br />ay-2012
-free-drugs-for-all/</a><br />
<br />
A paper exploring the links between rural indebtedness and healthcare costs in
Gurdaspur and Amritsar districts of Punjab<br />
<a href="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html" title="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html" title="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html" title="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html">http://www.epw.in/commentary/rural-healthcare-and-indebted<br />ness-pu
njab.html</a><br />
<br />
<em><span>Initiatives by state governments in Rajasthan and West Bengal to
provide access to affordable generic drugs:</span></em>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Mamata Banerjee battles for generic drugs, 16 March, 2012 
</p>
<p class="MsoNormal">
<a href="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/" title="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/" title="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/" title="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/">http://health.india.com/diseases-conditions/mamata-banerje<br />e-battl
es-for-generic-drugs/</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
India Poised to Supply Free
Drugs to 1.2 Billion People-Zofeen Ebrahim, 8 November, 2012<br />
<a href="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/" title="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/" title="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/" title="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/">http://www.ipsnews.net/2012/11/india-poised-to-supply-free<br />-drugs-
to-1-2-billion-people/</a>
</p>
<p class="MsoNormal">
There Is A
cure -Pragya Singh, Outlook, 27 July, 2009 
</p>
<p class="MsoNormal">
<a href="http://www.outlookindia.com/article.aspx?250525" title="http://www.outlookindia.com/article.aspx?250525" title="http://www.outlookindia.com/article.aspx?250525" title="http://www.outlookindia.com/article.aspx?250525">http://www.outlookindia.com/article.aspx?250525</a>
</p>
<p class="MsoNormal">
<br />
A field report on how the National Health Insurance system is working:<br />
<a href="http://www.who.int/bulletin/volumes/88/7/10-020710/en/" title="http://www.who.int/bulletin/volumes/88/7/10-020710/en/" title="http://www.who.int/bulletin/volumes/88/7/10-020710/en/" title="http://www.who.int/bulletin/volumes/88/7/10-020710/en/">http://www.who.int/bulletin/volumes/88/7/10-020710/en/</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Indian patent rulings may face legal heat internationally
-Soma Das <br />
The Economic Times, 11 April, 2013, <a href="https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html" title="http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html" title="https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html" title="http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html">http://www.im4change.org/latest-news-updates/indian-patent<br />-ruling
s-may-face-legal-heat-internationally-soma-das-20<br />409.html</a><br />
<br />
HIV, cancer patients seek access to affordable medicines-Aarti Dhar, <br />
<a href="https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html" title="http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html" title="https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html" title="http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html">The
Hindu, 11 April, 2013, http://www.im4change.org/lates<br />t-news-u
pdates/hiv-cancer-patients-seek-access-to-afford<br />able-medicines-aarti-dhar-20403.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Natco Pharma wins cancer drug case-R Sivaraman, The Hindu, 4
March, 2013, <a href="https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html" title="http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html" title="https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html" title="http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html">http://www.im4change.org/latest-news-updates/natco-pharma-<br />wins-ca
ncer-drug-case-r-sivaraman-19744.html </a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
EU, Australia, Canada may follow India&rsquo;s Patent Law -Divya
Rajagopal, The Economic Times, 4 April, 2013, <a href="https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html" title="http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html" title="https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html" title="http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html">http://www.im4change.org/latest-news-updates/eu-australia-<br />canada-
may-follow-indias-patent-law-divya-rajagopal-2030<br />7.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
When innovation is under threat-Swati Piramal, The Indian
Express, 2 April, 2013, <a href="https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html" title="http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html" title="https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html" title="http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html">http://www.im4change.org/latest-news-updates/when-innovati<br />on-is-u
nder-threat-swati-piramal-20286.html</a>&nbsp; 
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
YK Sapru, founder chairperson of Cancer Patients Aid Association
(CPAA) interviewed by Sushmi Dey, The Business Standard, 3 April, 2013, <a href="https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html" title="http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html" title="https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html" title="http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html">http://www.im4change.org/interviews/yk-sapru-founder-chair<br />person-
of-cancer-patients-aid-association-cpaa-interview<br />ed-by-sushmi-dey-20267.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
</div>
<div align="justify">
<span>Novartis
patent case: Glivec developer Brian Druker hails SC ruling- Chidanand
Rajghatta, The Economic Times, 3 April, 2013, <a href="https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html">http://www.im4change.org/latest-news-updates/novartis-patent-case</a></span>
</div>
<div align="justify">
<span><a href="https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html">-glivec-developer-brian-druker-hails-sc-ruling-chidanand-r<br />ajghatta-20265.html</a></span>
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
(एलर्ट में इस्तेमाल किए गए चित्र के लिए हम http://www.unn-edu.net/wp-content/uploads/2010/02/Medicine.jpg के आभारी हैं) <br />
</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f4edb79e549-trace').style.display = (document.getElementById('cakeErr67f4edb79e549-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f4edb79e549-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f4edb79e549-code').style.display = (document.getElementById('cakeErr67f4edb79e549-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f4edb79e549-context').style.display = (document.getElementById('cakeErr67f4edb79e549-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f4edb79e549-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f4edb79e549-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 46428,
		&#039;title&#039; =&gt; &#039;सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट के फैसले के बाद एक दफे फिर से देश में यह बहस शुरु हो गई है कि सरकारी स्वास्थ्य व्यवस्था लचर है और सरकार की स्वास्थ्य नीति हर जरुरतमंद को कम कीमत में दवा उपलब्ध करा पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
अध्ययनों का निष्कर्ष है कि भारत में स्वास्थ्य के मद में होने वाले खर्च का 70 फीसदी हिस्सा लोगों को अपनी जेब से देना पड़ता है और इस खर्च में दवा की खरीदारी पर 50-80 फीसदी हिस्सा व्यय होता है।&amp;nbsp; ग्रामीण विकास मंत्रालय का तो यह तक कहना है कि ग्रामीण भारतीयों के कर्ज में डूबे होने का सबसे बड़ा कारण बीमारियों के उपचार पर होने वाला खर्च है। &lt;br /&gt;
&lt;br /&gt;
कितनी विडंबनापूर्ण स्थिति है कि एक तरफ मरीज और उसके परिवार-जन को बीमारियों के उपचार का खर्च उठा पाना मुश्किल होता है जबकि दूसरी तरफ यह भी एक तथ्य है कि भारत का 100,000 करोड़ रुपये का दवा-उद्योग अपने आकार में विश्व में तीसरे स्थान पर है और एशिया तथा अफ्रीका के देशों में भारत की दवा-निर्माता कंपनियां सालाना 42000 करोड़ रुपये कीमत की जेनरिक(कम कीमत वाली) दवाइयां बेचती हैं।&lt;br /&gt;
&lt;br /&gt;
सरकार फिलहाल जीडीपी का .1 प्रतिशत(6000 करोड़ रुपये) ही दवाइयों के उपार्जन पर खर्च कर रही है। एक सरकारी रिपोर्ट में तर्क दिया गया है कि इस खर्च को बढाकर जीडीपी का 5 प्रतिशत कर दिया जाय तो &amp;ldquo; सरकारी और निजी अभिकरणों के जरिए सबको जरुरी दवाइयां मुफ्त दी जा सकती हैं।&amp;rdquo; &lt;br /&gt;
&lt;br /&gt;
इसके अतिरिक्त, अध्ययनकर्ताओं का कहना है कि सरकार घरेलू बाजार में दवा की कीमतों और बहुराष्ट्रीय दवा कंपनियों के कामकाज के संचालन के नियमन के लिए पर्याप्त प्रयास नहीं करती। सरकार द्वारा चलायी जा रही जन औषधि योजना के तहत दवा दुकानों से लोगों को उचित मूल्य पर दवा हासिल हो सके- सरकार ऐसा भी कर पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
बारहवीं पंचवर्षीय योजना (2013-17) में सरकारी स्वास्थ्य व्यवस्था को पुनर्जीवित करने की बात कही गई है। बहरहाल देखने वाली बात यह होगी कि क्या नीति-निर्माता लोगों की खरीद की पहुंच से बाहर जाती दवाइयों को किस हद तक उनकी पहुंच के दायरे में ला पाते हैं।&amp;nbsp;&amp;nbsp; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
इस कथा का विस्तार निम्नलिखित लिंक्स के सहारे किया जा सकता है- 
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Basic backgrounders on generics and why they are lesser
priced&lt;br /&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot;&gt;http://health.india.com/diseases-conditions/generic-drugs-what-yo&lt;br /&gt;
u-need-to-know/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot;&gt;http://www.who.int/trade/glossary/story034/en/&lt;/a&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Findings and recommendations by the government&amp;rsquo;s High Level
Expert Group (HLEG) on Universal Health Coverage (UHC), which submitted its
report in October 2010&lt;br /&gt;
&lt;a href=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot;&gt;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A report on meeting the challenges facing Indian pharma:&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot;&gt;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_ph&lt;br /&gt;
arma2902.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
The National Pharmaceutical Pricing Policy (NPPP-2012) which
was notified in November 2012 and seeks to regulate prices of 348 essential
medicines, and the Jan Aushadhi scheme for a network of public fair-price
medicine shops:
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot;&gt;www.nppaindia.nic.in&lt;/a&gt; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot;&gt;www.janaushadhi.gov.in&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Low-cost Jan Aushadhi stores to be re-invented, The Hindu
Business Line, July 27 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot;&gt;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadh&lt;br /&gt;
i-stores-to-be-reinvented/article3693097.ece&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;The implications of a failing public healthcare system for rural
Indians:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Public health system in India has collapsed: Ramesh, The
Hindu, 16 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot;&gt;http://www.thehindu.com/news/national/public-health-system-in-ind&lt;br /&gt;
ia-has-collapsed-ramesh/article4101836.ece &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Free drugs for all?-Nirmalya Dutta, 30 November, 2012,&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot;&gt;http://health.india.com/diseases-conditions/independence-day-2012&lt;br /&gt;
-free-drugs-for-all/&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
A paper exploring the links between rural indebtedness and healthcare costs in
Gurdaspur and Amritsar districts of Punjab&lt;br /&gt;
&lt;a href=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot;&gt;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-pu&lt;br /&gt;
njab.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;Initiatives by state governments in Rajasthan and West Bengal to
provide access to affordable generic drugs:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Mamata Banerjee battles for generic drugs, 16 March, 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot;&gt;http://health.india.com/diseases-conditions/mamata-banerjee-battl&lt;br /&gt;
es-for-generic-drugs/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
India Poised to Supply Free
Drugs to 1.2 Billion People-Zofeen Ebrahim, 8 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot;&gt;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-&lt;br /&gt;
to-1-2-billion-people/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
There Is A
cure -Pragya Singh, Outlook, 27 July, 2009 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot;&gt;http://www.outlookindia.com/article.aspx?250525&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A field report on how the National Health Insurance system is working:&lt;br /&gt;
&lt;a href=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot;&gt;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Indian patent rulings may face legal heat internationally
-Soma Das &lt;br /&gt;
The Economic Times, 11 April, 2013, &lt;a href=&quot;../latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot;&gt;http://www.im4change.org/latest-news-updates/indian-patent-ruling&lt;br /&gt;
s-may-face-legal-heat-internationally-soma-das-20409.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
HIV, cancer patients seek access to affordable medicines-Aarti Dhar, &lt;br /&gt;
&lt;a href=&quot;../latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot;&gt;The
Hindu, 11 April, 2013, http://www.im4change.org/latest-news-u&lt;br /&gt;
pdates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Natco Pharma wins cancer drug case-R Sivaraman, The Hindu, 4
March, 2013, &lt;a href=&quot;../latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot;&gt;http://www.im4change.org/latest-news-updates/natco-pharma-wins-ca&lt;br /&gt;
ncer-drug-case-r-sivaraman-19744.html &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
EU, Australia, Canada may follow India&amp;rsquo;s Patent Law -Divya
Rajagopal, The Economic Times, 4 April, 2013, &lt;a href=&quot;../latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot;&gt;http://www.im4change.org/latest-news-updates/eu-australia-canada-&lt;br /&gt;
may-follow-indias-patent-law-divya-rajagopal-20307.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
When innovation is under threat-Swati Piramal, The Indian
Express, 2 April, 2013, &lt;a href=&quot;../latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot;&gt;http://www.im4change.org/latest-news-updates/when-innovation-is-u&lt;br /&gt;
nder-threat-swati-piramal-20286.html&lt;/a&gt;&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
YK Sapru, founder chairperson of Cancer Patients Aid Association
(CPAA) interviewed by Sushmi Dey, The Business Standard, 3 April, 2013, &lt;a href=&quot;../interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot;&gt;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-&lt;br /&gt;
of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;Novartis
patent case: Glivec developer Brian Druker hails SC ruling- Chidanand
Rajghatta, The Economic Times, 3 April, 2013, &lt;a href=&quot;../latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;http://www.im4change.org/latest-news-updates/novartis-patent-case&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;&lt;a href=&quot;../latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
(एलर्ट में इस्तेमाल किए गए चित्र के लिए हम http://www.unn-edu.net/wp-content/uploads/2010/02/Medicine.jpg के आभारी हैं) &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;H&#039;,
		&#039;category_id&#039; =&gt; (int) 70,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;सुप्रीम-कोर्ट-का-फैसला-और-सस्ती-दवाइयों-का-मुद्दा-5584&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 5584,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 46428,
	&#039;metaTitle&#039; =&gt; &#039;चर्चा में.... | सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;स्वास्थ्य,सेहत,स्वास्थ्य,सेहत&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट के फैसले के बाद एक दफे फिर से देश में यह बहस शुरु हो गई है कि सरकारी स्वास्थ्य व्यवस्था लचर है और सरकार की स्वास्थ्य नीति हर जरुरतमंद को कम कीमत में दवा उपलब्ध करा पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
अध्ययनों का निष्कर्ष है कि भारत में स्वास्थ्य के मद में होने वाले खर्च का 70 फीसदी हिस्सा लोगों को अपनी जेब से देना पड़ता है और इस खर्च में दवा की खरीदारी पर 50-80 फीसदी हिस्सा व्यय होता है।&amp;nbsp; ग्रामीण विकास मंत्रालय का तो यह तक कहना है कि ग्रामीण भारतीयों के कर्ज में डूबे होने का सबसे बड़ा कारण बीमारियों के उपचार पर होने वाला खर्च है। &lt;br /&gt;
&lt;br /&gt;
कितनी विडंबनापूर्ण स्थिति है कि एक तरफ मरीज और उसके परिवार-जन को बीमारियों के उपचार का खर्च उठा पाना मुश्किल होता है जबकि दूसरी तरफ यह भी एक तथ्य है कि भारत का 100,000 करोड़ रुपये का दवा-उद्योग अपने आकार में विश्व में तीसरे स्थान पर है और एशिया तथा अफ्रीका के देशों में भारत की दवा-निर्माता कंपनियां सालाना 42000 करोड़ रुपये कीमत की जेनरिक(कम कीमत वाली) दवाइयां बेचती हैं।&lt;br /&gt;
&lt;br /&gt;
सरकार फिलहाल जीडीपी का .1 प्रतिशत(6000 करोड़ रुपये) ही दवाइयों के उपार्जन पर खर्च कर रही है। एक सरकारी रिपोर्ट में तर्क दिया गया है कि इस खर्च को बढाकर जीडीपी का 5 प्रतिशत कर दिया जाय तो &amp;ldquo; सरकारी और निजी अभिकरणों के जरिए सबको जरुरी दवाइयां मुफ्त दी जा सकती हैं।&amp;rdquo; &lt;br /&gt;
&lt;br /&gt;
इसके अतिरिक्त, अध्ययनकर्ताओं का कहना है कि सरकार घरेलू बाजार में दवा की कीमतों और बहुराष्ट्रीय दवा कंपनियों के कामकाज के संचालन के नियमन के लिए पर्याप्त प्रयास नहीं करती। सरकार द्वारा चलायी जा रही जन औषधि योजना के तहत दवा दुकानों से लोगों को उचित मूल्य पर दवा हासिल हो सके- सरकार ऐसा भी कर पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
बारहवीं पंचवर्षीय योजना (2013-17) में सरकारी स्वास्थ्य व्यवस्था को पुनर्जीवित करने की बात कही गई है। बहरहाल देखने वाली बात यह होगी कि क्या नीति-निर्माता लोगों की खरीद की पहुंच से बाहर जाती दवाइयों को किस हद तक उनकी पहुंच के दायरे में ला पाते हैं।&amp;nbsp;&amp;nbsp; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
इस कथा का विस्तार निम्नलिखित लिंक्स के सहारे किया जा सकता है- 
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Basic backgrounders on generics and why they are lesser
priced&lt;br /&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot;&gt;http://health.india.com/diseases-conditions/generic-drugs-&lt;br /&gt;what-yo
u-need-to-know/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot;&gt;http://www.who.int/trade/glossary/story034/en/&lt;/a&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Findings and recommendations by the government&amp;rsquo;s High Level
Expert Group (HLEG) on Universal Health Coverage (UHC), which submitted its
report in October 2010&lt;br /&gt;
&lt;a href=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot;&gt;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A report on meeting the challenges facing Indian pharma:&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot;&gt;http://planningcommission.nic.in/aboutus/committee/wrkgrp1&lt;br /&gt;2/wg_ph
arma2902.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
The National Pharmaceutical Pricing Policy (NPPP-2012) which
was notified in November 2012 and seeks to regulate prices of 348 essential
medicines, and the Jan Aushadhi scheme for a network of public fair-price
medicine shops:
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot;&gt;www.nppaindia.nic.in&lt;/a&gt; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot;&gt;www.janaushadhi.gov.in&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Low-cost Jan Aushadhi stores to be re-invented, The Hindu
Business Line, July 27 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot;&gt;http://www.thehindubusinessline.com/marketing/lowcost-jan-&lt;br /&gt;aushadh
i-stores-to-be-reinvented/article3693097.ece&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;The implications of a failing public healthcare system for rural
Indians:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Public health system in India has collapsed: Ramesh, The
Hindu, 16 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot;&gt;http://www.thehindu.com/news/national/public-health-system&lt;br /&gt;-in-ind
ia-has-collapsed-ramesh/article4101836.ece &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Free drugs for all?-Nirmalya Dutta, 30 November, 2012,&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot;&gt;http://health.india.com/diseases-conditions/independence-d&lt;br /&gt;ay-2012
-free-drugs-for-all/&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
A paper exploring the links between rural indebtedness and healthcare costs in
Gurdaspur and Amritsar districts of Punjab&lt;br /&gt;
&lt;a href=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot;&gt;http://www.epw.in/commentary/rural-healthcare-and-indebted&lt;br /&gt;ness-pu
njab.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;Initiatives by state governments in Rajasthan and West Bengal to
provide access to affordable generic drugs:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Mamata Banerjee battles for generic drugs, 16 March, 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot;&gt;http://health.india.com/diseases-conditions/mamata-banerje&lt;br /&gt;e-battl
es-for-generic-drugs/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
India Poised to Supply Free
Drugs to 1.2 Billion People-Zofeen Ebrahim, 8 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot;&gt;http://www.ipsnews.net/2012/11/india-poised-to-supply-free&lt;br /&gt;-drugs-
to-1-2-billion-people/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
There Is A
cure -Pragya Singh, Outlook, 27 July, 2009 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot;&gt;http://www.outlookindia.com/article.aspx?250525&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A field report on how the National Health Insurance system is working:&lt;br /&gt;
&lt;a href=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot;&gt;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Indian patent rulings may face legal heat internationally
-Soma Das &lt;br /&gt;
The Economic Times, 11 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot;&gt;http://www.im4change.org/latest-news-updates/indian-patent&lt;br /&gt;-ruling
s-may-face-legal-heat-internationally-soma-das-20&lt;br /&gt;409.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
HIV, cancer patients seek access to affordable medicines-Aarti Dhar, &lt;br /&gt;
&lt;a href=&quot;https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot;&gt;The
Hindu, 11 April, 2013, http://www.im4change.org/lates&lt;br /&gt;t-news-u
pdates/hiv-cancer-patients-seek-access-to-afford&lt;br /&gt;able-medicines-aarti-dhar-20403.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Natco Pharma wins cancer drug case-R Sivaraman, The Hindu, 4
March, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot;&gt;http://www.im4change.org/latest-news-updates/natco-pharma-&lt;br /&gt;wins-ca
ncer-drug-case-r-sivaraman-19744.html &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
EU, Australia, Canada may follow India&amp;rsquo;s Patent Law -Divya
Rajagopal, The Economic Times, 4 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot;&gt;http://www.im4change.org/latest-news-updates/eu-australia-&lt;br /&gt;canada-
may-follow-indias-patent-law-divya-rajagopal-2030&lt;br /&gt;7.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
When innovation is under threat-Swati Piramal, The Indian
Express, 2 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot;&gt;http://www.im4change.org/latest-news-updates/when-innovati&lt;br /&gt;on-is-u
nder-threat-swati-piramal-20286.html&lt;/a&gt;&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
YK Sapru, founder chairperson of Cancer Patients Aid Association
(CPAA) interviewed by Sushmi Dey, The Business Standard, 3 April, 2013, &lt;a href=&quot;https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot;&gt;http://www.im4change.org/interviews/yk-sapru-founder-chair&lt;br /&gt;person-
of-cancer-patients-aid-association-cpaa-interview&lt;br /&gt;ed-by-sushmi-dey-20267.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;Novartis
patent case: Glivec developer Brian Druker hails SC ruling- Chidanand
Rajghatta, The Economic Times, 3 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;http://www.im4change.org/latest-news-updates/novartis-patent-case&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;&lt;a href=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;-glivec-developer-brian-druker-hails-sc-ruling-chidanand-r&lt;br /&gt;ajghatta-20265.html&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
(एलर्ट में इस्तेमाल किए गए चित्र के लिए हम http://www.unn-edu.net/wp-content/uploads/2010/02/Medicine.jpg के आभारी हैं) &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;Hindi&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 46428,
	&#039;title&#039; =&gt; &#039;सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट के फैसले के बाद एक दफे फिर से देश में यह बहस शुरु हो गई है कि सरकारी स्वास्थ्य व्यवस्था लचर है और सरकार की स्वास्थ्य नीति हर जरुरतमंद को कम कीमत में दवा उपलब्ध करा पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
अध्ययनों का निष्कर्ष है कि भारत में स्वास्थ्य के मद में होने वाले खर्च का 70 फीसदी हिस्सा लोगों को अपनी जेब से देना पड़ता है और इस खर्च में दवा की खरीदारी पर 50-80 फीसदी हिस्सा व्यय होता है।&amp;nbsp; ग्रामीण विकास मंत्रालय का तो यह तक कहना है कि ग्रामीण भारतीयों के कर्ज में डूबे होने का सबसे बड़ा कारण बीमारियों के उपचार पर होने वाला खर्च है। &lt;br /&gt;
&lt;br /&gt;
कितनी विडंबनापूर्ण स्थिति है कि एक तरफ मरीज और उसके परिवार-जन को बीमारियों के उपचार का खर्च उठा पाना मुश्किल होता है जबकि दूसरी तरफ यह भी एक तथ्य है कि भारत का 100,000 करोड़ रुपये का दवा-उद्योग अपने आकार में विश्व में तीसरे स्थान पर है और एशिया तथा अफ्रीका के देशों में भारत की दवा-निर्माता कंपनियां सालाना 42000 करोड़ रुपये कीमत की जेनरिक(कम कीमत वाली) दवाइयां बेचती हैं।&lt;br /&gt;
&lt;br /&gt;
सरकार फिलहाल जीडीपी का .1 प्रतिशत(6000 करोड़ रुपये) ही दवाइयों के उपार्जन पर खर्च कर रही है। एक सरकारी रिपोर्ट में तर्क दिया गया है कि इस खर्च को बढाकर जीडीपी का 5 प्रतिशत कर दिया जाय तो &amp;ldquo; सरकारी और निजी अभिकरणों के जरिए सबको जरुरी दवाइयां मुफ्त दी जा सकती हैं।&amp;rdquo; &lt;br /&gt;
&lt;br /&gt;
इसके अतिरिक्त, अध्ययनकर्ताओं का कहना है कि सरकार घरेलू बाजार में दवा की कीमतों और बहुराष्ट्रीय दवा कंपनियों के कामकाज के संचालन के नियमन के लिए पर्याप्त प्रयास नहीं करती। सरकार द्वारा चलायी जा रही जन औषधि योजना के तहत दवा दुकानों से लोगों को उचित मूल्य पर दवा हासिल हो सके- सरकार ऐसा भी कर पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
बारहवीं पंचवर्षीय योजना (2013-17) में सरकारी स्वास्थ्य व्यवस्था को पुनर्जीवित करने की बात कही गई है। बहरहाल देखने वाली बात यह होगी कि क्या नीति-निर्माता लोगों की खरीद की पहुंच से बाहर जाती दवाइयों को किस हद तक उनकी पहुंच के दायरे में ला पाते हैं।&amp;nbsp;&amp;nbsp; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
इस कथा का विस्तार निम्नलिखित लिंक्स के सहारे किया जा सकता है- 
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Basic backgrounders on generics and why they are lesser
priced&lt;br /&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot;&gt;http://health.india.com/diseases-conditions/generic-drugs-what-yo&lt;br /&gt;
u-need-to-know/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot;&gt;http://www.who.int/trade/glossary/story034/en/&lt;/a&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Findings and recommendations by the government&amp;rsquo;s High Level
Expert Group (HLEG) on Universal Health Coverage (UHC), which submitted its
report in October 2010&lt;br /&gt;
&lt;a href=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot;&gt;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A report on meeting the challenges facing Indian pharma:&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot;&gt;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_ph&lt;br /&gt;
arma2902.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
The National Pharmaceutical Pricing Policy (NPPP-2012) which
was notified in November 2012 and seeks to regulate prices of 348 essential
medicines, and the Jan Aushadhi scheme for a network of public fair-price
medicine shops:
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot;&gt;www.nppaindia.nic.in&lt;/a&gt; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot;&gt;www.janaushadhi.gov.in&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Low-cost Jan Aushadhi stores to be re-invented, The Hindu
Business Line, July 27 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot;&gt;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadh&lt;br /&gt;
i-stores-to-be-reinvented/article3693097.ece&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;The implications of a failing public healthcare system for rural
Indians:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Public health system in India has collapsed: Ramesh, The
Hindu, 16 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot;&gt;http://www.thehindu.com/news/national/public-health-system-in-ind&lt;br /&gt;
ia-has-collapsed-ramesh/article4101836.ece &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Free drugs for all?-Nirmalya Dutta, 30 November, 2012,&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot;&gt;http://health.india.com/diseases-conditions/independence-day-2012&lt;br /&gt;
-free-drugs-for-all/&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
A paper exploring the links between rural indebtedness and healthcare costs in
Gurdaspur and Amritsar districts of Punjab&lt;br /&gt;
&lt;a href=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot;&gt;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-pu&lt;br /&gt;
njab.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;Initiatives by state governments in Rajasthan and West Bengal to
provide access to affordable generic drugs:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Mamata Banerjee battles for generic drugs, 16 March, 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot;&gt;http://health.india.com/diseases-conditions/mamata-banerjee-battl&lt;br /&gt;
es-for-generic-drugs/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
India Poised to Supply Free
Drugs to 1.2 Billion People-Zofeen Ebrahim, 8 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot;&gt;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-&lt;br /&gt;
to-1-2-billion-people/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
There Is A
cure -Pragya Singh, Outlook, 27 July, 2009 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot;&gt;http://www.outlookindia.com/article.aspx?250525&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A field report on how the National Health Insurance system is working:&lt;br /&gt;
&lt;a href=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot;&gt;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Indian patent rulings may face legal heat internationally
-Soma Das &lt;br /&gt;
The Economic Times, 11 April, 2013, &lt;a href=&quot;../latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot;&gt;http://www.im4change.org/latest-news-updates/indian-patent-ruling&lt;br /&gt;
s-may-face-legal-heat-internationally-soma-das-20409.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
HIV, cancer patients seek access to affordable medicines-Aarti Dhar, &lt;br /&gt;
&lt;a href=&quot;../latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot;&gt;The
Hindu, 11 April, 2013, http://www.im4change.org/latest-news-u&lt;br /&gt;
pdates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Natco Pharma wins cancer drug case-R Sivaraman, The Hindu, 4
March, 2013, &lt;a href=&quot;../latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot;&gt;http://www.im4change.org/latest-news-updates/natco-pharma-wins-ca&lt;br /&gt;
ncer-drug-case-r-sivaraman-19744.html &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
EU, Australia, Canada may follow India&amp;rsquo;s Patent Law -Divya
Rajagopal, The Economic Times, 4 April, 2013, &lt;a href=&quot;../latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot;&gt;http://www.im4change.org/latest-news-updates/eu-australia-canada-&lt;br /&gt;
may-follow-indias-patent-law-divya-rajagopal-20307.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
When innovation is under threat-Swati Piramal, The Indian
Express, 2 April, 2013, &lt;a href=&quot;../latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot;&gt;http://www.im4change.org/latest-news-updates/when-innovation-is-u&lt;br /&gt;
nder-threat-swati-piramal-20286.html&lt;/a&gt;&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
YK Sapru, founder chairperson of Cancer Patients Aid Association
(CPAA) interviewed by Sushmi Dey, The Business Standard, 3 April, 2013, &lt;a href=&quot;../interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot;&gt;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-&lt;br /&gt;
of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;Novartis
patent case: Glivec developer Brian Druker hails SC ruling- Chidanand
Rajghatta, The Economic Times, 3 April, 2013, &lt;a href=&quot;../latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;http://www.im4change.org/latest-news-updates/novartis-patent-case&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;&lt;a href=&quot;../latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
(एलर्ट में इस्तेमाल किए गए चित्र के लिए हम http://www.unn-edu.net/wp-content/uploads/2010/02/Medicine.jpg के आभारी हैं) &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;H&#039;,
	&#039;category_id&#039; =&gt; (int) 70,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;सुप्रीम-कोर्ट-का-फैसला-और-सस्ती-दवाइयों-का-मुद्दा-5584&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 5584,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 46428
$metaTitle = &#039;चर्चा में.... | सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा&#039;
$metaKeywords = &#039;स्वास्थ्य,सेहत,स्वास्थ्य,सेहत&#039;
$metaDesc = &#039;
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट के फैसले के बाद एक दफे फिर से देश में यह बहस शुरु हो गई है कि सरकारी स्वास्थ्य व्यवस्था लचर है और सरकार की स्वास्थ्य नीति हर जरुरतमंद को कम कीमत में दवा उपलब्ध करा पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
अध्ययनों का निष्कर्ष है कि भारत में स्वास्थ्य के मद में होने वाले खर्च का 70 फीसदी हिस्सा लोगों को अपनी जेब से देना पड़ता है और इस खर्च में दवा की खरीदारी पर 50-80 फीसदी हिस्सा व्यय होता है।&amp;nbsp; ग्रामीण विकास मंत्रालय का तो यह तक कहना है कि ग्रामीण भारतीयों के कर्ज में डूबे होने का सबसे बड़ा कारण बीमारियों के उपचार पर होने वाला खर्च है। &lt;br /&gt;
&lt;br /&gt;
कितनी विडंबनापूर्ण स्थिति है कि एक तरफ मरीज और उसके परिवार-जन को बीमारियों के उपचार का खर्च उठा पाना मुश्किल होता है जबकि दूसरी तरफ यह भी एक तथ्य है कि भारत का 100,000 करोड़ रुपये का दवा-उद्योग अपने आकार में विश्व में तीसरे स्थान पर है और एशिया तथा अफ्रीका के देशों में भारत की दवा-निर्माता कंपनियां सालाना 42000 करोड़ रुपये कीमत की जेनरिक(कम कीमत वाली) दवाइयां बेचती हैं।&lt;br /&gt;
&lt;br /&gt;
सरकार फिलहाल जीडीपी का .1 प्रतिशत(6000 करोड़ रुपये) ही दवाइयों के उपार्जन पर खर्च कर रही है। एक सरकारी रिपोर्ट में तर्क दिया गया है कि इस खर्च को बढाकर जीडीपी का 5 प्रतिशत कर दिया जाय तो &amp;ldquo; सरकारी और निजी अभिकरणों के जरिए सबको जरुरी दवाइयां मुफ्त दी जा सकती हैं।&amp;rdquo; &lt;br /&gt;
&lt;br /&gt;
इसके अतिरिक्त, अध्ययनकर्ताओं का कहना है कि सरकार घरेलू बाजार में दवा की कीमतों और बहुराष्ट्रीय दवा कंपनियों के कामकाज के संचालन के नियमन के लिए पर्याप्त प्रयास नहीं करती। सरकार द्वारा चलायी जा रही जन औषधि योजना के तहत दवा दुकानों से लोगों को उचित मूल्य पर दवा हासिल हो सके- सरकार ऐसा भी कर पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
बारहवीं पंचवर्षीय योजना (2013-17) में सरकारी स्वास्थ्य व्यवस्था को पुनर्जीवित करने की बात कही गई है। बहरहाल देखने वाली बात यह होगी कि क्या नीति-निर्माता लोगों की खरीद की पहुंच से बाहर जाती दवाइयों को किस हद तक उनकी पहुंच के दायरे में ला पाते हैं।&amp;nbsp;&amp;nbsp; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
इस कथा का विस्तार निम्नलिखित लिंक्स के सहारे किया जा सकता है- 
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Basic backgrounders on generics and why they are lesser
priced&lt;br /&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot;&gt;http://health.india.com/diseases-conditions/generic-drugs-&lt;br /&gt;what-yo
u-need-to-know/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot;&gt;http://www.who.int/trade/glossary/story034/en/&lt;/a&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Findings and recommendations by the government&amp;rsquo;s High Level
Expert Group (HLEG) on Universal Health Coverage (UHC), which submitted its
report in October 2010&lt;br /&gt;
&lt;a href=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot;&gt;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A report on meeting the challenges facing Indian pharma:&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot;&gt;http://planningcommission.nic.in/aboutus/committee/wrkgrp1&lt;br /&gt;2/wg_ph
arma2902.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
The National Pharmaceutical Pricing Policy (NPPP-2012) which
was notified in November 2012 and seeks to regulate prices of 348 essential
medicines, and the Jan Aushadhi scheme for a network of public fair-price
medicine shops:
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot;&gt;www.nppaindia.nic.in&lt;/a&gt; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot;&gt;www.janaushadhi.gov.in&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Low-cost Jan Aushadhi stores to be re-invented, The Hindu
Business Line, July 27 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot;&gt;http://www.thehindubusinessline.com/marketing/lowcost-jan-&lt;br /&gt;aushadh
i-stores-to-be-reinvented/article3693097.ece&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;The implications of a failing public healthcare system for rural
Indians:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Public health system in India has collapsed: Ramesh, The
Hindu, 16 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot;&gt;http://www.thehindu.com/news/national/public-health-system&lt;br /&gt;-in-ind
ia-has-collapsed-ramesh/article4101836.ece &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Free drugs for all?-Nirmalya Dutta, 30 November, 2012,&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot;&gt;http://health.india.com/diseases-conditions/independence-d&lt;br /&gt;ay-2012
-free-drugs-for-all/&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
A paper exploring the links between rural indebtedness and healthcare costs in
Gurdaspur and Amritsar districts of Punjab&lt;br /&gt;
&lt;a href=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot;&gt;http://www.epw.in/commentary/rural-healthcare-and-indebted&lt;br /&gt;ness-pu
njab.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;Initiatives by state governments in Rajasthan and West Bengal to
provide access to affordable generic drugs:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Mamata Banerjee battles for generic drugs, 16 March, 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot;&gt;http://health.india.com/diseases-conditions/mamata-banerje&lt;br /&gt;e-battl
es-for-generic-drugs/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
India Poised to Supply Free
Drugs to 1.2 Billion People-Zofeen Ebrahim, 8 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot;&gt;http://www.ipsnews.net/2012/11/india-poised-to-supply-free&lt;br /&gt;-drugs-
to-1-2-billion-people/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
There Is A
cure -Pragya Singh, Outlook, 27 July, 2009 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot;&gt;http://www.outlookindia.com/article.aspx?250525&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A field report on how the National Health Insurance system is working:&lt;br /&gt;
&lt;a href=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot;&gt;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Indian patent rulings may face legal heat internationally
-Soma Das &lt;br /&gt;
The Economic Times, 11 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot;&gt;http://www.im4change.org/latest-news-updates/indian-patent&lt;br /&gt;-ruling
s-may-face-legal-heat-internationally-soma-das-20&lt;br /&gt;409.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
HIV, cancer patients seek access to affordable medicines-Aarti Dhar, &lt;br /&gt;
&lt;a href=&quot;https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot;&gt;The
Hindu, 11 April, 2013, http://www.im4change.org/lates&lt;br /&gt;t-news-u
pdates/hiv-cancer-patients-seek-access-to-afford&lt;br /&gt;able-medicines-aarti-dhar-20403.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Natco Pharma wins cancer drug case-R Sivaraman, The Hindu, 4
March, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot;&gt;http://www.im4change.org/latest-news-updates/natco-pharma-&lt;br /&gt;wins-ca
ncer-drug-case-r-sivaraman-19744.html &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
EU, Australia, Canada may follow India&amp;rsquo;s Patent Law -Divya
Rajagopal, The Economic Times, 4 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot;&gt;http://www.im4change.org/latest-news-updates/eu-australia-&lt;br /&gt;canada-
may-follow-indias-patent-law-divya-rajagopal-2030&lt;br /&gt;7.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
When innovation is under threat-Swati Piramal, The Indian
Express, 2 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot;&gt;http://www.im4change.org/latest-news-updates/when-innovati&lt;br /&gt;on-is-u
nder-threat-swati-piramal-20286.html&lt;/a&gt;&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
YK Sapru, founder chairperson of Cancer Patients Aid Association
(CPAA) interviewed by Sushmi Dey, The Business Standard, 3 April, 2013, &lt;a href=&quot;https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot;&gt;http://www.im4change.org/interviews/yk-sapru-founder-chair&lt;br /&gt;person-
of-cancer-patients-aid-association-cpaa-interview&lt;br /&gt;ed-by-sushmi-dey-20267.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;Novartis
patent case: Glivec developer Brian Druker hails SC ruling- Chidanand
Rajghatta, The Economic Times, 3 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;http://www.im4change.org/latest-news-updates/novartis-patent-case&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;&lt;a href=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;-glivec-developer-brian-druker-hails-sc-ruling-chidanand-r&lt;br /&gt;ajghatta-20265.html&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
(एलर्ट में इस्तेमाल किए गए चित्र के लिए हम http://www.unn-edu.net/wp-content/uploads/2010/02/Medicine.jpg के आभारी हैं) &lt;br /&gt;
&lt;/div&gt;&#039;
$lang = &#039;Hindi&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>news-alerts-57/सुप्रीम-कोर्ट-का-फैसला-और-सस्ती-दवाइयों-का-मुद्दा-5584.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>चर्चा में.... | सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा | Im4change.org</title>
    <meta name="description" content="
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट के फैसले के बाद एक दफे फिर से देश में यह बहस शुरु हो गई है कि सरकारी स्वास्थ्य व्यवस्था लचर है और सरकार की स्वास्थ्य नीति हर जरुरतमंद को कम कीमत में दवा उपलब्ध करा पाने में नाकाम रही है। <br />
<br />
अध्ययनों का निष्कर्ष है कि भारत में स्वास्थ्य के मद में होने वाले खर्च का 70 फीसदी हिस्सा लोगों को अपनी जेब से देना पड़ता है और इस खर्च में दवा की खरीदारी पर 50-80 फीसदी हिस्सा व्यय होता है।&nbsp; ग्रामीण विकास मंत्रालय का तो यह तक कहना है कि ग्रामीण भारतीयों के कर्ज में डूबे होने का सबसे बड़ा कारण बीमारियों के उपचार पर होने वाला खर्च है। <br />
<br />
कितनी विडंबनापूर्ण स्थिति है कि एक तरफ मरीज और उसके परिवार-जन को बीमारियों के उपचार का खर्च उठा पाना मुश्किल होता है जबकि दूसरी तरफ यह भी एक तथ्य है कि भारत का 100,000 करोड़ रुपये का दवा-उद्योग अपने आकार में विश्व में तीसरे स्थान पर है और एशिया तथा अफ्रीका के देशों में भारत की दवा-निर्माता कंपनियां सालाना 42000 करोड़ रुपये कीमत की जेनरिक(कम कीमत वाली) दवाइयां बेचती हैं।<br />
<br />
सरकार फिलहाल जीडीपी का .1 प्रतिशत(6000 करोड़ रुपये) ही दवाइयों के उपार्जन पर खर्च कर रही है। एक सरकारी रिपोर्ट में तर्क दिया गया है कि इस खर्च को बढाकर जीडीपी का 5 प्रतिशत कर दिया जाय तो &ldquo; सरकारी और निजी अभिकरणों के जरिए सबको जरुरी दवाइयां मुफ्त दी जा सकती हैं।&rdquo; <br />
<br />
इसके अतिरिक्त, अध्ययनकर्ताओं का कहना है कि सरकार घरेलू बाजार में दवा की कीमतों और बहुराष्ट्रीय दवा कंपनियों के कामकाज के संचालन के नियमन के लिए पर्याप्त प्रयास नहीं करती। सरकार द्वारा चलायी जा रही जन औषधि योजना के तहत दवा दुकानों से लोगों को उचित मूल्य पर दवा हासिल हो सके- सरकार ऐसा भी कर पाने में नाकाम रही है। <br />
<br />
बारहवीं पंचवर्षीय योजना (2013-17) में सरकारी स्वास्थ्य व्यवस्था को पुनर्जीवित करने की बात कही गई है। बहरहाल देखने वाली बात यह होगी कि क्या नीति-निर्माता लोगों की खरीद की पहुंच से बाहर जाती दवाइयों को किस हद तक उनकी पहुंच के दायरे में ला पाते हैं।&nbsp;&nbsp; &nbsp;<br />
<br />
इस कथा का विस्तार निम्नलिखित लिंक्स के सहारे किया जा सकता है- 
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
<p class="MsoNormal">
Basic backgrounders on generics and why they are lesser
priced<br />
<a href="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/" title="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/" title="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/" title="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/">http://health.india.com/diseases-conditions/generic-drugs-<br />what-yo
u-need-to-know/</a>
</p>
<p class="MsoNormal">
<a href="http://www.who.int/trade/glossary/story034/en/" title="http://www.who.int/trade/glossary/story034/en/" title="http://www.who.int/trade/glossary/story034/en/" title="http://www.who.int/trade/glossary/story034/en/">http://www.who.int/trade/glossary/story034/en/</a>
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Findings and recommendations by the government&rsquo;s High Level
Expert Group (HLEG) on Universal Health Coverage (UHC), which submitted its
report in October 2010<br />
<a href="http://uhc-india.org/reports/hleg_report_chapter_3.pdf" title="http://uhc-india.org/reports/hleg_report_chapter_3.pdf" title="http://uhc-india.org/reports/hleg_report_chapter_3.pdf" title="http://uhc-india.org/reports/hleg_report_chapter_3.pdf">http://uhc-india.org/reports/hleg_report_chapter_3.pdf</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
<br />
A report on meeting the challenges facing Indian pharma:&nbsp; 
</p>
<p class="MsoNormal">
<a href="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf" title="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf" title="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf" title="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf">http://planningcommission.nic.in/aboutus/committee/wrkgrp1<br />2/wg_ph
arma2902.pdf</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
The National Pharmaceutical Pricing Policy (NPPP-2012) which
was notified in November 2012 and seeks to regulate prices of 348 essential
medicines, and the Jan Aushadhi scheme for a network of public fair-price
medicine shops:
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
<a href="http://www.nppaindia.nic.in" title="http://www.nppaindia.nic.in" title="http://www.nppaindia.nic.in" title="http://www.nppaindia.nic.in">www.nppaindia.nic.in</a> &nbsp;<br />
<br />
<a href="http://www.janaushadhi.gov.in" title="http://www.janaushadhi.gov.in" title="http://www.janaushadhi.gov.in" title="http://www.janaushadhi.gov.in">www.janaushadhi.gov.in</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Low-cost Jan Aushadhi stores to be re-invented, The Hindu
Business Line, July 27 2012 
</p>
<p class="MsoNormal">
<a href="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece" title="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece" title="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece" title="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece">http://www.thehindubusinessline.com/marketing/lowcost-jan-<br />aushadh
i-stores-to-be-reinvented/article3693097.ece</a><br />
<br />
<em><span>The implications of a failing public healthcare system for rural
Indians:</span></em>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Public health system in India has collapsed: Ramesh, The
Hindu, 16 November, 2012<br />
<a href="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece" title="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece" title="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece" title="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece">http://www.thehindu.com/news/national/public-health-system<br />-in-ind
ia-has-collapsed-ramesh/article4101836.ece </a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Free drugs for all?-Nirmalya Dutta, 30 November, 2012,&nbsp;
</p>
<p class="MsoNormal">
<a href="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/" title="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/" title="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/" title="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/">http://health.india.com/diseases-conditions/independence-d<br />ay-2012
-free-drugs-for-all/</a><br />
<br />
A paper exploring the links between rural indebtedness and healthcare costs in
Gurdaspur and Amritsar districts of Punjab<br />
<a href="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html" title="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html" title="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html" title="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html">http://www.epw.in/commentary/rural-healthcare-and-indebted<br />ness-pu
njab.html</a><br />
<br />
<em><span>Initiatives by state governments in Rajasthan and West Bengal to
provide access to affordable generic drugs:</span></em>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Mamata Banerjee battles for generic drugs, 16 March, 2012 
</p>
<p class="MsoNormal">
<a href="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/" title="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/" title="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/" title="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/">http://health.india.com/diseases-conditions/mamata-banerje<br />e-battl
es-for-generic-drugs/</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
India Poised to Supply Free
Drugs to 1.2 Billion People-Zofeen Ebrahim, 8 November, 2012<br />
<a href="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/" title="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/" title="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/" title="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/">http://www.ipsnews.net/2012/11/india-poised-to-supply-free<br />-drugs-
to-1-2-billion-people/</a>
</p>
<p class="MsoNormal">
There Is A
cure -Pragya Singh, Outlook, 27 July, 2009 
</p>
<p class="MsoNormal">
<a href="http://www.outlookindia.com/article.aspx?250525" title="http://www.outlookindia.com/article.aspx?250525" title="http://www.outlookindia.com/article.aspx?250525" title="http://www.outlookindia.com/article.aspx?250525">http://www.outlookindia.com/article.aspx?250525</a>
</p>
<p class="MsoNormal">
<br />
A field report on how the National Health Insurance system is working:<br />
<a href="http://www.who.int/bulletin/volumes/88/7/10-020710/en/" title="http://www.who.int/bulletin/volumes/88/7/10-020710/en/" title="http://www.who.int/bulletin/volumes/88/7/10-020710/en/" title="http://www.who.int/bulletin/volumes/88/7/10-020710/en/">http://www.who.int/bulletin/volumes/88/7/10-020710/en/</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Indian patent rulings may face legal heat internationally
-Soma Das <br />
The Economic Times, 11 April, 2013, <a href="https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html" title="http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html" title="https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html" title="http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html">http://www.im4change.org/latest-news-updates/indian-patent<br />-ruling
s-may-face-legal-heat-internationally-soma-das-20<br />409.html</a><br />
<br />
HIV, cancer patients seek access to affordable medicines-Aarti Dhar, <br />
<a href="https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html" title="http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html" title="https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html" title="http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html">The
Hindu, 11 April, 2013, http://www.im4change.org/lates<br />t-news-u
pdates/hiv-cancer-patients-seek-access-to-afford<br />able-medicines-aarti-dhar-20403.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Natco Pharma wins cancer drug case-R Sivaraman, The Hindu, 4
March, 2013, <a href="https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html" title="http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html" title="https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html" title="http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html">http://www.im4change.org/latest-news-updates/natco-pharma-<br />wins-ca
ncer-drug-case-r-sivaraman-19744.html </a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
EU, Australia, Canada may follow India&rsquo;s Patent Law -Divya
Rajagopal, The Economic Times, 4 April, 2013, <a href="https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html" title="http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html" title="https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html" title="http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html">http://www.im4change.org/latest-news-updates/eu-australia-<br />canada-
may-follow-indias-patent-law-divya-rajagopal-2030<br />7.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
When innovation is under threat-Swati Piramal, The Indian
Express, 2 April, 2013, <a href="https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html" title="http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html" title="https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html" title="http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html">http://www.im4change.org/latest-news-updates/when-innovati<br />on-is-u
nder-threat-swati-piramal-20286.html</a>&nbsp; 
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
YK Sapru, founder chairperson of Cancer Patients Aid Association
(CPAA) interviewed by Sushmi Dey, The Business Standard, 3 April, 2013, <a href="https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html" title="http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html" title="https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html" title="http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html">http://www.im4change.org/interviews/yk-sapru-founder-chair<br />person-
of-cancer-patients-aid-association-cpaa-interview<br />ed-by-sushmi-dey-20267.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
</div>
<div align="justify">
<span>Novartis
patent case: Glivec developer Brian Druker hails SC ruling- Chidanand
Rajghatta, The Economic Times, 3 April, 2013, <a href="https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html">http://www.im4change.org/latest-news-updates/novartis-patent-case</a></span>
</div>
<div align="justify">
<span><a href="https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html">-glivec-developer-brian-druker-hails-sc-ruling-chidanand-r<br />ajghatta-20265.html</a></span>
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
(एलर्ट में इस्तेमाल किए गए चित्र के लिए हम http://www.unn-edu.net/wp-content/uploads/2010/02/Medicine.jpg के आभारी हैं) <br />
</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f4edb79e549-trace').style.display = (document.getElementById('cakeErr67f4edb79e549-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f4edb79e549-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f4edb79e549-code').style.display = (document.getElementById('cakeErr67f4edb79e549-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f4edb79e549-context').style.display = (document.getElementById('cakeErr67f4edb79e549-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f4edb79e549-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f4edb79e549-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 46428,
		&#039;title&#039; =&gt; &#039;सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट के फैसले के बाद एक दफे फिर से देश में यह बहस शुरु हो गई है कि सरकारी स्वास्थ्य व्यवस्था लचर है और सरकार की स्वास्थ्य नीति हर जरुरतमंद को कम कीमत में दवा उपलब्ध करा पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
अध्ययनों का निष्कर्ष है कि भारत में स्वास्थ्य के मद में होने वाले खर्च का 70 फीसदी हिस्सा लोगों को अपनी जेब से देना पड़ता है और इस खर्च में दवा की खरीदारी पर 50-80 फीसदी हिस्सा व्यय होता है।&amp;nbsp; ग्रामीण विकास मंत्रालय का तो यह तक कहना है कि ग्रामीण भारतीयों के कर्ज में डूबे होने का सबसे बड़ा कारण बीमारियों के उपचार पर होने वाला खर्च है। &lt;br /&gt;
&lt;br /&gt;
कितनी विडंबनापूर्ण स्थिति है कि एक तरफ मरीज और उसके परिवार-जन को बीमारियों के उपचार का खर्च उठा पाना मुश्किल होता है जबकि दूसरी तरफ यह भी एक तथ्य है कि भारत का 100,000 करोड़ रुपये का दवा-उद्योग अपने आकार में विश्व में तीसरे स्थान पर है और एशिया तथा अफ्रीका के देशों में भारत की दवा-निर्माता कंपनियां सालाना 42000 करोड़ रुपये कीमत की जेनरिक(कम कीमत वाली) दवाइयां बेचती हैं।&lt;br /&gt;
&lt;br /&gt;
सरकार फिलहाल जीडीपी का .1 प्रतिशत(6000 करोड़ रुपये) ही दवाइयों के उपार्जन पर खर्च कर रही है। एक सरकारी रिपोर्ट में तर्क दिया गया है कि इस खर्च को बढाकर जीडीपी का 5 प्रतिशत कर दिया जाय तो &amp;ldquo; सरकारी और निजी अभिकरणों के जरिए सबको जरुरी दवाइयां मुफ्त दी जा सकती हैं।&amp;rdquo; &lt;br /&gt;
&lt;br /&gt;
इसके अतिरिक्त, अध्ययनकर्ताओं का कहना है कि सरकार घरेलू बाजार में दवा की कीमतों और बहुराष्ट्रीय दवा कंपनियों के कामकाज के संचालन के नियमन के लिए पर्याप्त प्रयास नहीं करती। सरकार द्वारा चलायी जा रही जन औषधि योजना के तहत दवा दुकानों से लोगों को उचित मूल्य पर दवा हासिल हो सके- सरकार ऐसा भी कर पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
बारहवीं पंचवर्षीय योजना (2013-17) में सरकारी स्वास्थ्य व्यवस्था को पुनर्जीवित करने की बात कही गई है। बहरहाल देखने वाली बात यह होगी कि क्या नीति-निर्माता लोगों की खरीद की पहुंच से बाहर जाती दवाइयों को किस हद तक उनकी पहुंच के दायरे में ला पाते हैं।&amp;nbsp;&amp;nbsp; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
इस कथा का विस्तार निम्नलिखित लिंक्स के सहारे किया जा सकता है- 
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Basic backgrounders on generics and why they are lesser
priced&lt;br /&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot;&gt;http://health.india.com/diseases-conditions/generic-drugs-what-yo&lt;br /&gt;
u-need-to-know/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot;&gt;http://www.who.int/trade/glossary/story034/en/&lt;/a&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Findings and recommendations by the government&amp;rsquo;s High Level
Expert Group (HLEG) on Universal Health Coverage (UHC), which submitted its
report in October 2010&lt;br /&gt;
&lt;a href=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot;&gt;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A report on meeting the challenges facing Indian pharma:&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot;&gt;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_ph&lt;br /&gt;
arma2902.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
The National Pharmaceutical Pricing Policy (NPPP-2012) which
was notified in November 2012 and seeks to regulate prices of 348 essential
medicines, and the Jan Aushadhi scheme for a network of public fair-price
medicine shops:
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot;&gt;www.nppaindia.nic.in&lt;/a&gt; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot;&gt;www.janaushadhi.gov.in&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Low-cost Jan Aushadhi stores to be re-invented, The Hindu
Business Line, July 27 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot;&gt;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadh&lt;br /&gt;
i-stores-to-be-reinvented/article3693097.ece&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;The implications of a failing public healthcare system for rural
Indians:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Public health system in India has collapsed: Ramesh, The
Hindu, 16 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot;&gt;http://www.thehindu.com/news/national/public-health-system-in-ind&lt;br /&gt;
ia-has-collapsed-ramesh/article4101836.ece &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Free drugs for all?-Nirmalya Dutta, 30 November, 2012,&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot;&gt;http://health.india.com/diseases-conditions/independence-day-2012&lt;br /&gt;
-free-drugs-for-all/&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
A paper exploring the links between rural indebtedness and healthcare costs in
Gurdaspur and Amritsar districts of Punjab&lt;br /&gt;
&lt;a href=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot;&gt;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-pu&lt;br /&gt;
njab.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;Initiatives by state governments in Rajasthan and West Bengal to
provide access to affordable generic drugs:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Mamata Banerjee battles for generic drugs, 16 March, 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot;&gt;http://health.india.com/diseases-conditions/mamata-banerjee-battl&lt;br /&gt;
es-for-generic-drugs/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
India Poised to Supply Free
Drugs to 1.2 Billion People-Zofeen Ebrahim, 8 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot;&gt;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-&lt;br /&gt;
to-1-2-billion-people/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
There Is A
cure -Pragya Singh, Outlook, 27 July, 2009 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot;&gt;http://www.outlookindia.com/article.aspx?250525&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A field report on how the National Health Insurance system is working:&lt;br /&gt;
&lt;a href=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot;&gt;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Indian patent rulings may face legal heat internationally
-Soma Das &lt;br /&gt;
The Economic Times, 11 April, 2013, &lt;a href=&quot;../latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot;&gt;http://www.im4change.org/latest-news-updates/indian-patent-ruling&lt;br /&gt;
s-may-face-legal-heat-internationally-soma-das-20409.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
HIV, cancer patients seek access to affordable medicines-Aarti Dhar, &lt;br /&gt;
&lt;a href=&quot;../latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot;&gt;The
Hindu, 11 April, 2013, http://www.im4change.org/latest-news-u&lt;br /&gt;
pdates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Natco Pharma wins cancer drug case-R Sivaraman, The Hindu, 4
March, 2013, &lt;a href=&quot;../latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot;&gt;http://www.im4change.org/latest-news-updates/natco-pharma-wins-ca&lt;br /&gt;
ncer-drug-case-r-sivaraman-19744.html &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
EU, Australia, Canada may follow India&amp;rsquo;s Patent Law -Divya
Rajagopal, The Economic Times, 4 April, 2013, &lt;a href=&quot;../latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot;&gt;http://www.im4change.org/latest-news-updates/eu-australia-canada-&lt;br /&gt;
may-follow-indias-patent-law-divya-rajagopal-20307.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
When innovation is under threat-Swati Piramal, The Indian
Express, 2 April, 2013, &lt;a href=&quot;../latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot;&gt;http://www.im4change.org/latest-news-updates/when-innovation-is-u&lt;br /&gt;
nder-threat-swati-piramal-20286.html&lt;/a&gt;&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
YK Sapru, founder chairperson of Cancer Patients Aid Association
(CPAA) interviewed by Sushmi Dey, The Business Standard, 3 April, 2013, &lt;a href=&quot;../interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot;&gt;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-&lt;br /&gt;
of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;Novartis
patent case: Glivec developer Brian Druker hails SC ruling- Chidanand
Rajghatta, The Economic Times, 3 April, 2013, &lt;a href=&quot;../latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;http://www.im4change.org/latest-news-updates/novartis-patent-case&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;&lt;a href=&quot;../latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
(एलर्ट में इस्तेमाल किए गए चित्र के लिए हम http://www.unn-edu.net/wp-content/uploads/2010/02/Medicine.jpg के आभारी हैं) &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;H&#039;,
		&#039;category_id&#039; =&gt; (int) 70,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;सुप्रीम-कोर्ट-का-फैसला-और-सस्ती-दवाइयों-का-मुद्दा-5584&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 5584,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 46428,
	&#039;metaTitle&#039; =&gt; &#039;चर्चा में.... | सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;स्वास्थ्य,सेहत,स्वास्थ्य,सेहत&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट के फैसले के बाद एक दफे फिर से देश में यह बहस शुरु हो गई है कि सरकारी स्वास्थ्य व्यवस्था लचर है और सरकार की स्वास्थ्य नीति हर जरुरतमंद को कम कीमत में दवा उपलब्ध करा पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
अध्ययनों का निष्कर्ष है कि भारत में स्वास्थ्य के मद में होने वाले खर्च का 70 फीसदी हिस्सा लोगों को अपनी जेब से देना पड़ता है और इस खर्च में दवा की खरीदारी पर 50-80 फीसदी हिस्सा व्यय होता है।&amp;nbsp; ग्रामीण विकास मंत्रालय का तो यह तक कहना है कि ग्रामीण भारतीयों के कर्ज में डूबे होने का सबसे बड़ा कारण बीमारियों के उपचार पर होने वाला खर्च है। &lt;br /&gt;
&lt;br /&gt;
कितनी विडंबनापूर्ण स्थिति है कि एक तरफ मरीज और उसके परिवार-जन को बीमारियों के उपचार का खर्च उठा पाना मुश्किल होता है जबकि दूसरी तरफ यह भी एक तथ्य है कि भारत का 100,000 करोड़ रुपये का दवा-उद्योग अपने आकार में विश्व में तीसरे स्थान पर है और एशिया तथा अफ्रीका के देशों में भारत की दवा-निर्माता कंपनियां सालाना 42000 करोड़ रुपये कीमत की जेनरिक(कम कीमत वाली) दवाइयां बेचती हैं।&lt;br /&gt;
&lt;br /&gt;
सरकार फिलहाल जीडीपी का .1 प्रतिशत(6000 करोड़ रुपये) ही दवाइयों के उपार्जन पर खर्च कर रही है। एक सरकारी रिपोर्ट में तर्क दिया गया है कि इस खर्च को बढाकर जीडीपी का 5 प्रतिशत कर दिया जाय तो &amp;ldquo; सरकारी और निजी अभिकरणों के जरिए सबको जरुरी दवाइयां मुफ्त दी जा सकती हैं।&amp;rdquo; &lt;br /&gt;
&lt;br /&gt;
इसके अतिरिक्त, अध्ययनकर्ताओं का कहना है कि सरकार घरेलू बाजार में दवा की कीमतों और बहुराष्ट्रीय दवा कंपनियों के कामकाज के संचालन के नियमन के लिए पर्याप्त प्रयास नहीं करती। सरकार द्वारा चलायी जा रही जन औषधि योजना के तहत दवा दुकानों से लोगों को उचित मूल्य पर दवा हासिल हो सके- सरकार ऐसा भी कर पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
बारहवीं पंचवर्षीय योजना (2013-17) में सरकारी स्वास्थ्य व्यवस्था को पुनर्जीवित करने की बात कही गई है। बहरहाल देखने वाली बात यह होगी कि क्या नीति-निर्माता लोगों की खरीद की पहुंच से बाहर जाती दवाइयों को किस हद तक उनकी पहुंच के दायरे में ला पाते हैं।&amp;nbsp;&amp;nbsp; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
इस कथा का विस्तार निम्नलिखित लिंक्स के सहारे किया जा सकता है- 
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Basic backgrounders on generics and why they are lesser
priced&lt;br /&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot;&gt;http://health.india.com/diseases-conditions/generic-drugs-&lt;br /&gt;what-yo
u-need-to-know/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot;&gt;http://www.who.int/trade/glossary/story034/en/&lt;/a&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Findings and recommendations by the government&amp;rsquo;s High Level
Expert Group (HLEG) on Universal Health Coverage (UHC), which submitted its
report in October 2010&lt;br /&gt;
&lt;a href=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot;&gt;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A report on meeting the challenges facing Indian pharma:&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot;&gt;http://planningcommission.nic.in/aboutus/committee/wrkgrp1&lt;br /&gt;2/wg_ph
arma2902.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
The National Pharmaceutical Pricing Policy (NPPP-2012) which
was notified in November 2012 and seeks to regulate prices of 348 essential
medicines, and the Jan Aushadhi scheme for a network of public fair-price
medicine shops:
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot;&gt;www.nppaindia.nic.in&lt;/a&gt; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot;&gt;www.janaushadhi.gov.in&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Low-cost Jan Aushadhi stores to be re-invented, The Hindu
Business Line, July 27 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot;&gt;http://www.thehindubusinessline.com/marketing/lowcost-jan-&lt;br /&gt;aushadh
i-stores-to-be-reinvented/article3693097.ece&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;The implications of a failing public healthcare system for rural
Indians:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Public health system in India has collapsed: Ramesh, The
Hindu, 16 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot;&gt;http://www.thehindu.com/news/national/public-health-system&lt;br /&gt;-in-ind
ia-has-collapsed-ramesh/article4101836.ece &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Free drugs for all?-Nirmalya Dutta, 30 November, 2012,&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot;&gt;http://health.india.com/diseases-conditions/independence-d&lt;br /&gt;ay-2012
-free-drugs-for-all/&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
A paper exploring the links between rural indebtedness and healthcare costs in
Gurdaspur and Amritsar districts of Punjab&lt;br /&gt;
&lt;a href=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot;&gt;http://www.epw.in/commentary/rural-healthcare-and-indebted&lt;br /&gt;ness-pu
njab.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;Initiatives by state governments in Rajasthan and West Bengal to
provide access to affordable generic drugs:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Mamata Banerjee battles for generic drugs, 16 March, 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot;&gt;http://health.india.com/diseases-conditions/mamata-banerje&lt;br /&gt;e-battl
es-for-generic-drugs/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
India Poised to Supply Free
Drugs to 1.2 Billion People-Zofeen Ebrahim, 8 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot;&gt;http://www.ipsnews.net/2012/11/india-poised-to-supply-free&lt;br /&gt;-drugs-
to-1-2-billion-people/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
There Is A
cure -Pragya Singh, Outlook, 27 July, 2009 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot;&gt;http://www.outlookindia.com/article.aspx?250525&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A field report on how the National Health Insurance system is working:&lt;br /&gt;
&lt;a href=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot;&gt;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Indian patent rulings may face legal heat internationally
-Soma Das &lt;br /&gt;
The Economic Times, 11 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot;&gt;http://www.im4change.org/latest-news-updates/indian-patent&lt;br /&gt;-ruling
s-may-face-legal-heat-internationally-soma-das-20&lt;br /&gt;409.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
HIV, cancer patients seek access to affordable medicines-Aarti Dhar, &lt;br /&gt;
&lt;a href=&quot;https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot;&gt;The
Hindu, 11 April, 2013, http://www.im4change.org/lates&lt;br /&gt;t-news-u
pdates/hiv-cancer-patients-seek-access-to-afford&lt;br /&gt;able-medicines-aarti-dhar-20403.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Natco Pharma wins cancer drug case-R Sivaraman, The Hindu, 4
March, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot;&gt;http://www.im4change.org/latest-news-updates/natco-pharma-&lt;br /&gt;wins-ca
ncer-drug-case-r-sivaraman-19744.html &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
EU, Australia, Canada may follow India&amp;rsquo;s Patent Law -Divya
Rajagopal, The Economic Times, 4 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot;&gt;http://www.im4change.org/latest-news-updates/eu-australia-&lt;br /&gt;canada-
may-follow-indias-patent-law-divya-rajagopal-2030&lt;br /&gt;7.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
When innovation is under threat-Swati Piramal, The Indian
Express, 2 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot;&gt;http://www.im4change.org/latest-news-updates/when-innovati&lt;br /&gt;on-is-u
nder-threat-swati-piramal-20286.html&lt;/a&gt;&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
YK Sapru, founder chairperson of Cancer Patients Aid Association
(CPAA) interviewed by Sushmi Dey, The Business Standard, 3 April, 2013, &lt;a href=&quot;https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot;&gt;http://www.im4change.org/interviews/yk-sapru-founder-chair&lt;br /&gt;person-
of-cancer-patients-aid-association-cpaa-interview&lt;br /&gt;ed-by-sushmi-dey-20267.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;Novartis
patent case: Glivec developer Brian Druker hails SC ruling- Chidanand
Rajghatta, The Economic Times, 3 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;http://www.im4change.org/latest-news-updates/novartis-patent-case&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;&lt;a href=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;-glivec-developer-brian-druker-hails-sc-ruling-chidanand-r&lt;br /&gt;ajghatta-20265.html&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
(एलर्ट में इस्तेमाल किए गए चित्र के लिए हम http://www.unn-edu.net/wp-content/uploads/2010/02/Medicine.jpg के आभारी हैं) &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;Hindi&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 46428,
	&#039;title&#039; =&gt; &#039;सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट के फैसले के बाद एक दफे फिर से देश में यह बहस शुरु हो गई है कि सरकारी स्वास्थ्य व्यवस्था लचर है और सरकार की स्वास्थ्य नीति हर जरुरतमंद को कम कीमत में दवा उपलब्ध करा पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
अध्ययनों का निष्कर्ष है कि भारत में स्वास्थ्य के मद में होने वाले खर्च का 70 फीसदी हिस्सा लोगों को अपनी जेब से देना पड़ता है और इस खर्च में दवा की खरीदारी पर 50-80 फीसदी हिस्सा व्यय होता है।&amp;nbsp; ग्रामीण विकास मंत्रालय का तो यह तक कहना है कि ग्रामीण भारतीयों के कर्ज में डूबे होने का सबसे बड़ा कारण बीमारियों के उपचार पर होने वाला खर्च है। &lt;br /&gt;
&lt;br /&gt;
कितनी विडंबनापूर्ण स्थिति है कि एक तरफ मरीज और उसके परिवार-जन को बीमारियों के उपचार का खर्च उठा पाना मुश्किल होता है जबकि दूसरी तरफ यह भी एक तथ्य है कि भारत का 100,000 करोड़ रुपये का दवा-उद्योग अपने आकार में विश्व में तीसरे स्थान पर है और एशिया तथा अफ्रीका के देशों में भारत की दवा-निर्माता कंपनियां सालाना 42000 करोड़ रुपये कीमत की जेनरिक(कम कीमत वाली) दवाइयां बेचती हैं।&lt;br /&gt;
&lt;br /&gt;
सरकार फिलहाल जीडीपी का .1 प्रतिशत(6000 करोड़ रुपये) ही दवाइयों के उपार्जन पर खर्च कर रही है। एक सरकारी रिपोर्ट में तर्क दिया गया है कि इस खर्च को बढाकर जीडीपी का 5 प्रतिशत कर दिया जाय तो &amp;ldquo; सरकारी और निजी अभिकरणों के जरिए सबको जरुरी दवाइयां मुफ्त दी जा सकती हैं।&amp;rdquo; &lt;br /&gt;
&lt;br /&gt;
इसके अतिरिक्त, अध्ययनकर्ताओं का कहना है कि सरकार घरेलू बाजार में दवा की कीमतों और बहुराष्ट्रीय दवा कंपनियों के कामकाज के संचालन के नियमन के लिए पर्याप्त प्रयास नहीं करती। सरकार द्वारा चलायी जा रही जन औषधि योजना के तहत दवा दुकानों से लोगों को उचित मूल्य पर दवा हासिल हो सके- सरकार ऐसा भी कर पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
बारहवीं पंचवर्षीय योजना (2013-17) में सरकारी स्वास्थ्य व्यवस्था को पुनर्जीवित करने की बात कही गई है। बहरहाल देखने वाली बात यह होगी कि क्या नीति-निर्माता लोगों की खरीद की पहुंच से बाहर जाती दवाइयों को किस हद तक उनकी पहुंच के दायरे में ला पाते हैं।&amp;nbsp;&amp;nbsp; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
इस कथा का विस्तार निम्नलिखित लिंक्स के सहारे किया जा सकता है- 
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Basic backgrounders on generics and why they are lesser
priced&lt;br /&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot;&gt;http://health.india.com/diseases-conditions/generic-drugs-what-yo&lt;br /&gt;
u-need-to-know/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot;&gt;http://www.who.int/trade/glossary/story034/en/&lt;/a&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Findings and recommendations by the government&amp;rsquo;s High Level
Expert Group (HLEG) on Universal Health Coverage (UHC), which submitted its
report in October 2010&lt;br /&gt;
&lt;a href=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot;&gt;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A report on meeting the challenges facing Indian pharma:&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot;&gt;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_ph&lt;br /&gt;
arma2902.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
The National Pharmaceutical Pricing Policy (NPPP-2012) which
was notified in November 2012 and seeks to regulate prices of 348 essential
medicines, and the Jan Aushadhi scheme for a network of public fair-price
medicine shops:
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot;&gt;www.nppaindia.nic.in&lt;/a&gt; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot;&gt;www.janaushadhi.gov.in&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Low-cost Jan Aushadhi stores to be re-invented, The Hindu
Business Line, July 27 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot;&gt;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadh&lt;br /&gt;
i-stores-to-be-reinvented/article3693097.ece&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;The implications of a failing public healthcare system for rural
Indians:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Public health system in India has collapsed: Ramesh, The
Hindu, 16 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot;&gt;http://www.thehindu.com/news/national/public-health-system-in-ind&lt;br /&gt;
ia-has-collapsed-ramesh/article4101836.ece &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Free drugs for all?-Nirmalya Dutta, 30 November, 2012,&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot;&gt;http://health.india.com/diseases-conditions/independence-day-2012&lt;br /&gt;
-free-drugs-for-all/&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
A paper exploring the links between rural indebtedness and healthcare costs in
Gurdaspur and Amritsar districts of Punjab&lt;br /&gt;
&lt;a href=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot;&gt;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-pu&lt;br /&gt;
njab.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;Initiatives by state governments in Rajasthan and West Bengal to
provide access to affordable generic drugs:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Mamata Banerjee battles for generic drugs, 16 March, 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot;&gt;http://health.india.com/diseases-conditions/mamata-banerjee-battl&lt;br /&gt;
es-for-generic-drugs/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
India Poised to Supply Free
Drugs to 1.2 Billion People-Zofeen Ebrahim, 8 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot;&gt;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-&lt;br /&gt;
to-1-2-billion-people/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
There Is A
cure -Pragya Singh, Outlook, 27 July, 2009 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot;&gt;http://www.outlookindia.com/article.aspx?250525&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A field report on how the National Health Insurance system is working:&lt;br /&gt;
&lt;a href=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot;&gt;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Indian patent rulings may face legal heat internationally
-Soma Das &lt;br /&gt;
The Economic Times, 11 April, 2013, &lt;a href=&quot;../latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot;&gt;http://www.im4change.org/latest-news-updates/indian-patent-ruling&lt;br /&gt;
s-may-face-legal-heat-internationally-soma-das-20409.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
HIV, cancer patients seek access to affordable medicines-Aarti Dhar, &lt;br /&gt;
&lt;a href=&quot;../latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot;&gt;The
Hindu, 11 April, 2013, http://www.im4change.org/latest-news-u&lt;br /&gt;
pdates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Natco Pharma wins cancer drug case-R Sivaraman, The Hindu, 4
March, 2013, &lt;a href=&quot;../latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot;&gt;http://www.im4change.org/latest-news-updates/natco-pharma-wins-ca&lt;br /&gt;
ncer-drug-case-r-sivaraman-19744.html &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
EU, Australia, Canada may follow India&amp;rsquo;s Patent Law -Divya
Rajagopal, The Economic Times, 4 April, 2013, &lt;a href=&quot;../latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot;&gt;http://www.im4change.org/latest-news-updates/eu-australia-canada-&lt;br /&gt;
may-follow-indias-patent-law-divya-rajagopal-20307.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
When innovation is under threat-Swati Piramal, The Indian
Express, 2 April, 2013, &lt;a href=&quot;../latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot;&gt;http://www.im4change.org/latest-news-updates/when-innovation-is-u&lt;br /&gt;
nder-threat-swati-piramal-20286.html&lt;/a&gt;&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
YK Sapru, founder chairperson of Cancer Patients Aid Association
(CPAA) interviewed by Sushmi Dey, The Business Standard, 3 April, 2013, &lt;a href=&quot;../interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot;&gt;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-&lt;br /&gt;
of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;Novartis
patent case: Glivec developer Brian Druker hails SC ruling- Chidanand
Rajghatta, The Economic Times, 3 April, 2013, &lt;a href=&quot;../latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;http://www.im4change.org/latest-news-updates/novartis-patent-case&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;&lt;a href=&quot;../latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
(एलर्ट में इस्तेमाल किए गए चित्र के लिए हम http://www.unn-edu.net/wp-content/uploads/2010/02/Medicine.jpg के आभारी हैं) &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;H&#039;,
	&#039;category_id&#039; =&gt; (int) 70,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;सुप्रीम-कोर्ट-का-फैसला-और-सस्ती-दवाइयों-का-मुद्दा-5584&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 5584,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 46428
$metaTitle = &#039;चर्चा में.... | सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा&#039;
$metaKeywords = &#039;स्वास्थ्य,सेहत,स्वास्थ्य,सेहत&#039;
$metaDesc = &#039;
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट के फैसले के बाद एक दफे फिर से देश में यह बहस शुरु हो गई है कि सरकारी स्वास्थ्य व्यवस्था लचर है और सरकार की स्वास्थ्य नीति हर जरुरतमंद को कम कीमत में दवा उपलब्ध करा पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
अध्ययनों का निष्कर्ष है कि भारत में स्वास्थ्य के मद में होने वाले खर्च का 70 फीसदी हिस्सा लोगों को अपनी जेब से देना पड़ता है और इस खर्च में दवा की खरीदारी पर 50-80 फीसदी हिस्सा व्यय होता है।&amp;nbsp; ग्रामीण विकास मंत्रालय का तो यह तक कहना है कि ग्रामीण भारतीयों के कर्ज में डूबे होने का सबसे बड़ा कारण बीमारियों के उपचार पर होने वाला खर्च है। &lt;br /&gt;
&lt;br /&gt;
कितनी विडंबनापूर्ण स्थिति है कि एक तरफ मरीज और उसके परिवार-जन को बीमारियों के उपचार का खर्च उठा पाना मुश्किल होता है जबकि दूसरी तरफ यह भी एक तथ्य है कि भारत का 100,000 करोड़ रुपये का दवा-उद्योग अपने आकार में विश्व में तीसरे स्थान पर है और एशिया तथा अफ्रीका के देशों में भारत की दवा-निर्माता कंपनियां सालाना 42000 करोड़ रुपये कीमत की जेनरिक(कम कीमत वाली) दवाइयां बेचती हैं।&lt;br /&gt;
&lt;br /&gt;
सरकार फिलहाल जीडीपी का .1 प्रतिशत(6000 करोड़ रुपये) ही दवाइयों के उपार्जन पर खर्च कर रही है। एक सरकारी रिपोर्ट में तर्क दिया गया है कि इस खर्च को बढाकर जीडीपी का 5 प्रतिशत कर दिया जाय तो &amp;ldquo; सरकारी और निजी अभिकरणों के जरिए सबको जरुरी दवाइयां मुफ्त दी जा सकती हैं।&amp;rdquo; &lt;br /&gt;
&lt;br /&gt;
इसके अतिरिक्त, अध्ययनकर्ताओं का कहना है कि सरकार घरेलू बाजार में दवा की कीमतों और बहुराष्ट्रीय दवा कंपनियों के कामकाज के संचालन के नियमन के लिए पर्याप्त प्रयास नहीं करती। सरकार द्वारा चलायी जा रही जन औषधि योजना के तहत दवा दुकानों से लोगों को उचित मूल्य पर दवा हासिल हो सके- सरकार ऐसा भी कर पाने में नाकाम रही है। &lt;br /&gt;
&lt;br /&gt;
बारहवीं पंचवर्षीय योजना (2013-17) में सरकारी स्वास्थ्य व्यवस्था को पुनर्जीवित करने की बात कही गई है। बहरहाल देखने वाली बात यह होगी कि क्या नीति-निर्माता लोगों की खरीद की पहुंच से बाहर जाती दवाइयों को किस हद तक उनकी पहुंच के दायरे में ला पाते हैं।&amp;nbsp;&amp;nbsp; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
इस कथा का विस्तार निम्नलिखित लिंक्स के सहारे किया जा सकता है- 
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Basic backgrounders on generics and why they are lesser
priced&lt;br /&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot; title=&quot;http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/&quot;&gt;http://health.india.com/diseases-conditions/generic-drugs-&lt;br /&gt;what-yo
u-need-to-know/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot; title=&quot;http://www.who.int/trade/glossary/story034/en/&quot;&gt;http://www.who.int/trade/glossary/story034/en/&lt;/a&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Findings and recommendations by the government&amp;rsquo;s High Level
Expert Group (HLEG) on Universal Health Coverage (UHC), which submitted its
report in October 2010&lt;br /&gt;
&lt;a href=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot; title=&quot;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&quot;&gt;http://uhc-india.org/reports/hleg_report_chapter_3.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A report on meeting the challenges facing Indian pharma:&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot; title=&quot;http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf&quot;&gt;http://planningcommission.nic.in/aboutus/committee/wrkgrp1&lt;br /&gt;2/wg_ph
arma2902.pdf&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
The National Pharmaceutical Pricing Policy (NPPP-2012) which
was notified in November 2012 and seeks to regulate prices of 348 essential
medicines, and the Jan Aushadhi scheme for a network of public fair-price
medicine shops:
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot; title=&quot;http://www.nppaindia.nic.in&quot;&gt;www.nppaindia.nic.in&lt;/a&gt; &amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot; title=&quot;http://www.janaushadhi.gov.in&quot;&gt;www.janaushadhi.gov.in&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Low-cost Jan Aushadhi stores to be re-invented, The Hindu
Business Line, July 27 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot; title=&quot;http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece&quot;&gt;http://www.thehindubusinessline.com/marketing/lowcost-jan-&lt;br /&gt;aushadh
i-stores-to-be-reinvented/article3693097.ece&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;The implications of a failing public healthcare system for rural
Indians:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Public health system in India has collapsed: Ramesh, The
Hindu, 16 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot; title=&quot;http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece&quot;&gt;http://www.thehindu.com/news/national/public-health-system&lt;br /&gt;-in-ind
ia-has-collapsed-ramesh/article4101836.ece &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Free drugs for all?-Nirmalya Dutta, 30 November, 2012,&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot; title=&quot;http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/&quot;&gt;http://health.india.com/diseases-conditions/independence-d&lt;br /&gt;ay-2012
-free-drugs-for-all/&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
A paper exploring the links between rural indebtedness and healthcare costs in
Gurdaspur and Amritsar districts of Punjab&lt;br /&gt;
&lt;a href=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot; title=&quot;http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html&quot;&gt;http://www.epw.in/commentary/rural-healthcare-and-indebted&lt;br /&gt;ness-pu
njab.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;&lt;span&gt;Initiatives by state governments in Rajasthan and West Bengal to
provide access to affordable generic drugs:&lt;/span&gt;&lt;/em&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Mamata Banerjee battles for generic drugs, 16 March, 2012 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot; title=&quot;http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/&quot;&gt;http://health.india.com/diseases-conditions/mamata-banerje&lt;br /&gt;e-battl
es-for-generic-drugs/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
India Poised to Supply Free
Drugs to 1.2 Billion People-Zofeen Ebrahim, 8 November, 2012&lt;br /&gt;
&lt;a href=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot; title=&quot;http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/&quot;&gt;http://www.ipsnews.net/2012/11/india-poised-to-supply-free&lt;br /&gt;-drugs-
to-1-2-billion-people/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
There Is A
cure -Pragya Singh, Outlook, 27 July, 2009 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;a href=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot; title=&quot;http://www.outlookindia.com/article.aspx?250525&quot;&gt;http://www.outlookindia.com/article.aspx?250525&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&lt;br /&gt;
A field report on how the National Health Insurance system is working:&lt;br /&gt;
&lt;a href=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot; title=&quot;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&quot;&gt;http://www.who.int/bulletin/volumes/88/7/10-020710/en/&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Indian patent rulings may face legal heat internationally
-Soma Das &lt;br /&gt;
The Economic Times, 11 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html&quot;&gt;http://www.im4change.org/latest-news-updates/indian-patent&lt;br /&gt;-ruling
s-may-face-legal-heat-internationally-soma-das-20&lt;br /&gt;409.html&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
HIV, cancer patients seek access to affordable medicines-Aarti Dhar, &lt;br /&gt;
&lt;a href=&quot;https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html&quot;&gt;The
Hindu, 11 April, 2013, http://www.im4change.org/lates&lt;br /&gt;t-news-u
pdates/hiv-cancer-patients-seek-access-to-afford&lt;br /&gt;able-medicines-aarti-dhar-20403.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
Natco Pharma wins cancer drug case-R Sivaraman, The Hindu, 4
March, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html&quot;&gt;http://www.im4change.org/latest-news-updates/natco-pharma-&lt;br /&gt;wins-ca
ncer-drug-case-r-sivaraman-19744.html &lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
EU, Australia, Canada may follow India&amp;rsquo;s Patent Law -Divya
Rajagopal, The Economic Times, 4 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html&quot;&gt;http://www.im4change.org/latest-news-updates/eu-australia-&lt;br /&gt;canada-
may-follow-indias-patent-law-divya-rajagopal-2030&lt;br /&gt;7.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
When innovation is under threat-Swati Piramal, The Indian
Express, 2 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html&quot;&gt;http://www.im4change.org/latest-news-updates/when-innovati&lt;br /&gt;on-is-u
nder-threat-swati-piramal-20286.html&lt;/a&gt;&amp;nbsp; 
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
YK Sapru, founder chairperson of Cancer Patients Aid Association
(CPAA) interviewed by Sushmi Dey, The Business Standard, 3 April, 2013, &lt;a href=&quot;https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot; title=&quot;http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html&quot;&gt;http://www.im4change.org/interviews/yk-sapru-founder-chair&lt;br /&gt;person-
of-cancer-patients-aid-association-cpaa-interview&lt;br /&gt;ed-by-sushmi-dey-20267.html&lt;/a&gt;
&lt;/p&gt;
&lt;p class=&quot;MsoNormal&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;Novartis
patent case: Glivec developer Brian Druker hails SC ruling- Chidanand
Rajghatta, The Economic Times, 3 April, 2013, &lt;a href=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;http://www.im4change.org/latest-news-updates/novartis-patent-case&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;span&gt;&lt;a href=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot; title=&quot;http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html&quot;&gt;-glivec-developer-brian-druker-hails-sc-ruling-chidanand-r&lt;br /&gt;ajghatta-20265.html&lt;/a&gt;&lt;/span&gt;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
(एलर्ट में इस्तेमाल किए गए चित्र के लिए हम http://www.unn-edu.net/wp-content/uploads/2010/02/Medicine.jpg के आभारी हैं) &lt;br /&gt;
&lt;/div&gt;&#039;
$lang = &#039;Hindi&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>news-alerts-57/सुप्रीम-कोर्ट-का-फैसला-और-सस्ती-दवाइयों-का-मुद्दा-5584.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>चर्चा में.... | सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा | Im4change.org</title>
    <meta name="description" content="
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट के फैसले के बाद एक दफे फिर से देश में यह बहस शुरु हो गई है कि सरकारी स्वास्थ्य व्यवस्था लचर है और सरकार की स्वास्थ्य नीति हर जरुरतमंद को कम कीमत में दवा उपलब्ध करा पाने में नाकाम रही है। <br />
<br />
अध्ययनों का निष्कर्ष है कि भारत में स्वास्थ्य के मद में होने वाले खर्च का 70 फीसदी हिस्सा लोगों को अपनी जेब से देना पड़ता है और इस खर्च में दवा की खरीदारी पर 50-80 फीसदी हिस्सा व्यय होता है।&nbsp; ग्रामीण विकास मंत्रालय का तो यह तक कहना है कि ग्रामीण भारतीयों के कर्ज में डूबे होने का सबसे बड़ा कारण बीमारियों के उपचार पर होने वाला खर्च है। <br />
<br />
कितनी विडंबनापूर्ण स्थिति है कि एक तरफ मरीज और उसके परिवार-जन को बीमारियों के उपचार का खर्च उठा पाना मुश्किल होता है जबकि दूसरी तरफ यह भी एक तथ्य है कि भारत का 100,000 करोड़ रुपये का दवा-उद्योग अपने आकार में विश्व में तीसरे स्थान पर है और एशिया तथा अफ्रीका के देशों में भारत की दवा-निर्माता कंपनियां सालाना 42000 करोड़ रुपये कीमत की जेनरिक(कम कीमत वाली) दवाइयां बेचती हैं।<br />
<br />
सरकार फिलहाल जीडीपी का .1 प्रतिशत(6000 करोड़ रुपये) ही दवाइयों के उपार्जन पर खर्च कर रही है। एक सरकारी रिपोर्ट में तर्क दिया गया है कि इस खर्च को बढाकर जीडीपी का 5 प्रतिशत कर दिया जाय तो &ldquo; सरकारी और निजी अभिकरणों के जरिए सबको जरुरी दवाइयां मुफ्त दी जा सकती हैं।&rdquo; <br />
<br />
इसके अतिरिक्त, अध्ययनकर्ताओं का कहना है कि सरकार घरेलू बाजार में दवा की कीमतों और बहुराष्ट्रीय दवा कंपनियों के कामकाज के संचालन के नियमन के लिए पर्याप्त प्रयास नहीं करती। सरकार द्वारा चलायी जा रही जन औषधि योजना के तहत दवा दुकानों से लोगों को उचित मूल्य पर दवा हासिल हो सके- सरकार ऐसा भी कर पाने में नाकाम रही है। <br />
<br />
बारहवीं पंचवर्षीय योजना (2013-17) में सरकारी स्वास्थ्य व्यवस्था को पुनर्जीवित करने की बात कही गई है। बहरहाल देखने वाली बात यह होगी कि क्या नीति-निर्माता लोगों की खरीद की पहुंच से बाहर जाती दवाइयों को किस हद तक उनकी पहुंच के दायरे में ला पाते हैं।&nbsp;&nbsp; &nbsp;<br />
<br />
इस कथा का विस्तार निम्नलिखित लिंक्स के सहारे किया जा सकता है- 
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
<p class="MsoNormal">
Basic backgrounders on generics and why they are lesser
priced<br />
<a href="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/" title="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/" title="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/" title="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/">http://health.india.com/diseases-conditions/generic-drugs-<br />what-yo
u-need-to-know/</a>
</p>
<p class="MsoNormal">
<a href="http://www.who.int/trade/glossary/story034/en/" title="http://www.who.int/trade/glossary/story034/en/" title="http://www.who.int/trade/glossary/story034/en/" title="http://www.who.int/trade/glossary/story034/en/">http://www.who.int/trade/glossary/story034/en/</a>
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Findings and recommendations by the government&rsquo;s High Level
Expert Group (HLEG) on Universal Health Coverage (UHC), which submitted its
report in October 2010<br />
<a href="http://uhc-india.org/reports/hleg_report_chapter_3.pdf" title="http://uhc-india.org/reports/hleg_report_chapter_3.pdf" title="http://uhc-india.org/reports/hleg_report_chapter_3.pdf" title="http://uhc-india.org/reports/hleg_report_chapter_3.pdf">http://uhc-india.org/reports/hleg_report_chapter_3.pdf</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
<br />
A report on meeting the challenges facing Indian pharma:&nbsp; 
</p>
<p class="MsoNormal">
<a href="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf" title="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf" title="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf" title="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf">http://planningcommission.nic.in/aboutus/committee/wrkgrp1<br />2/wg_ph
arma2902.pdf</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
The National Pharmaceutical Pricing Policy (NPPP-2012) which
was notified in November 2012 and seeks to regulate prices of 348 essential
medicines, and the Jan Aushadhi scheme for a network of public fair-price
medicine shops:
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
<a href="http://www.nppaindia.nic.in" title="http://www.nppaindia.nic.in" title="http://www.nppaindia.nic.in" title="http://www.nppaindia.nic.in">www.nppaindia.nic.in</a> &nbsp;<br />
<br />
<a href="http://www.janaushadhi.gov.in" title="http://www.janaushadhi.gov.in" title="http://www.janaushadhi.gov.in" title="http://www.janaushadhi.gov.in">www.janaushadhi.gov.in</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Low-cost Jan Aushadhi stores to be re-invented, The Hindu
Business Line, July 27 2012 
</p>
<p class="MsoNormal">
<a href="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece" title="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece" title="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece" title="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece">http://www.thehindubusinessline.com/marketing/lowcost-jan-<br />aushadh
i-stores-to-be-reinvented/article3693097.ece</a><br />
<br />
<em><span>The implications of a failing public healthcare system for rural
Indians:</span></em>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Public health system in India has collapsed: Ramesh, The
Hindu, 16 November, 2012<br />
<a href="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece" title="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece" title="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece" title="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece">http://www.thehindu.com/news/national/public-health-system<br />-in-ind
ia-has-collapsed-ramesh/article4101836.ece </a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Free drugs for all?-Nirmalya Dutta, 30 November, 2012,&nbsp;
</p>
<p class="MsoNormal">
<a href="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/" title="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/" title="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/" title="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/">http://health.india.com/diseases-conditions/independence-d<br />ay-2012
-free-drugs-for-all/</a><br />
<br />
A paper exploring the links between rural indebtedness and healthcare costs in
Gurdaspur and Amritsar districts of Punjab<br />
<a href="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html" title="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html" title="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html" title="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html">http://www.epw.in/commentary/rural-healthcare-and-indebted<br />ness-pu
njab.html</a><br />
<br />
<em><span>Initiatives by state governments in Rajasthan and West Bengal to
provide access to affordable generic drugs:</span></em>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Mamata Banerjee battles for generic drugs, 16 March, 2012 
</p>
<p class="MsoNormal">
<a href="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/" title="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/" title="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/" title="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/">http://health.india.com/diseases-conditions/mamata-banerje<br />e-battl
es-for-generic-drugs/</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
India Poised to Supply Free
Drugs to 1.2 Billion People-Zofeen Ebrahim, 8 November, 2012<br />
<a href="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/" title="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/" title="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/" title="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/">http://www.ipsnews.net/2012/11/india-poised-to-supply-free<br />-drugs-
to-1-2-billion-people/</a>
</p>
<p class="MsoNormal">
There Is A
cure -Pragya Singh, Outlook, 27 July, 2009 
</p>
<p class="MsoNormal">
<a href="http://www.outlookindia.com/article.aspx?250525" title="http://www.outlookindia.com/article.aspx?250525" title="http://www.outlookindia.com/article.aspx?250525" title="http://www.outlookindia.com/article.aspx?250525">http://www.outlookindia.com/article.aspx?250525</a>
</p>
<p class="MsoNormal">
<br />
A field report on how the National Health Insurance system is working:<br />
<a href="http://www.who.int/bulletin/volumes/88/7/10-020710/en/" title="http://www.who.int/bulletin/volumes/88/7/10-020710/en/" title="http://www.who.int/bulletin/volumes/88/7/10-020710/en/" title="http://www.who.int/bulletin/volumes/88/7/10-020710/en/">http://www.who.int/bulletin/volumes/88/7/10-020710/en/</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Indian patent rulings may face legal heat internationally
-Soma Das <br />
The Economic Times, 11 April, 2013, <a href="https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html" title="http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html" title="https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html" title="http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html">http://www.im4change.org/latest-news-updates/indian-patent<br />-ruling
s-may-face-legal-heat-internationally-soma-das-20<br />409.html</a><br />
<br />
HIV, cancer patients seek access to affordable medicines-Aarti Dhar, <br />
<a href="https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html" title="http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html" title="https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html" title="http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html">The
Hindu, 11 April, 2013, http://www.im4change.org/lates<br />t-news-u
pdates/hiv-cancer-patients-seek-access-to-afford<br />able-medicines-aarti-dhar-20403.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Natco Pharma wins cancer drug case-R Sivaraman, The Hindu, 4
March, 2013, <a href="https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html" title="http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html" title="https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html" title="http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html">http://www.im4change.org/latest-news-updates/natco-pharma-<br />wins-ca
ncer-drug-case-r-sivaraman-19744.html </a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
EU, Australia, Canada may follow India&rsquo;s Patent Law -Divya
Rajagopal, The Economic Times, 4 April, 2013, <a href="https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html" title="http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html" title="https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html" title="http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html">http://www.im4change.org/latest-news-updates/eu-australia-<br />canada-
may-follow-indias-patent-law-divya-rajagopal-2030<br />7.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
When innovation is under threat-Swati Piramal, The Indian
Express, 2 April, 2013, <a href="https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html" title="http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html" title="https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html" title="http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html">http://www.im4change.org/latest-news-updates/when-innovati<br />on-is-u
nder-threat-swati-piramal-20286.html</a>&nbsp; 
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
YK Sapru, founder chairperson of Cancer Patients Aid Association
(CPAA) interviewed by Sushmi Dey, The Business Standard, 3 April, 2013, <a href="https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html" title="http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html" title="https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html" title="http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html">http://www.im4change.org/interviews/yk-sapru-founder-chair<br />person-
of-cancer-patients-aid-association-cpaa-interview<br />ed-by-sushmi-dey-20267.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
</div>
<div align="justify">
<span>Novartis
patent case: Glivec developer Brian Druker hails SC ruling- Chidanand
Rajghatta, The Economic Times, 3 April, 2013, <a href="https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html">http://www.im4change.org/latest-news-updates/novartis-patent-case</a></span>
</div>
<div align="justify">
<span><a href="https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html">-glivec-developer-brian-druker-hails-sc-ruling-chidanand-r<br />ajghatta-20265.html</a></span>
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
(एलर्ट में इस्तेमाल किए गए चित्र के लिए हम http://www.unn-edu.net/wp-content/uploads/2010/02/Medicine.jpg के आभारी हैं) <br />
</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 46428,
		'title' => 'सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा',
		'subheading' => '',
		'description' => '<div align="justify">
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट के फैसले के बाद एक दफे फिर से देश में यह बहस शुरु हो गई है कि सरकारी स्वास्थ्य व्यवस्था लचर है और सरकार की स्वास्थ्य नीति हर जरुरतमंद को कम कीमत में दवा उपलब्ध करा पाने में नाकाम रही है। <br />
<br />
अध्ययनों का निष्कर्ष है कि भारत में स्वास्थ्य के मद में होने वाले खर्च का 70 फीसदी हिस्सा लोगों को अपनी जेब से देना पड़ता है और इस खर्च में दवा की खरीदारी पर 50-80 फीसदी हिस्सा व्यय होता है।&nbsp; ग्रामीण विकास मंत्रालय का तो यह तक कहना है कि ग्रामीण भारतीयों के कर्ज में डूबे होने का सबसे बड़ा कारण बीमारियों के उपचार पर होने वाला खर्च है। <br />
<br />
कितनी विडंबनापूर्ण स्थिति है कि एक तरफ मरीज और उसके परिवार-जन को बीमारियों के उपचार का खर्च उठा पाना मुश्किल होता है जबकि दूसरी तरफ यह भी एक तथ्य है कि भारत का 100,000 करोड़ रुपये का दवा-उद्योग अपने आकार में विश्व में तीसरे स्थान पर है और एशिया तथा अफ्रीका के देशों में भारत की दवा-निर्माता कंपनियां सालाना 42000 करोड़ रुपये कीमत की जेनरिक(कम कीमत वाली) दवाइयां बेचती हैं।<br />
<br />
सरकार फिलहाल जीडीपी का .1 प्रतिशत(6000 करोड़ रुपये) ही दवाइयों के उपार्जन पर खर्च कर रही है। एक सरकारी रिपोर्ट में तर्क दिया गया है कि इस खर्च को बढाकर जीडीपी का 5 प्रतिशत कर दिया जाय तो &ldquo; सरकारी और निजी अभिकरणों के जरिए सबको जरुरी दवाइयां मुफ्त दी जा सकती हैं।&rdquo; <br />
<br />
इसके अतिरिक्त, अध्ययनकर्ताओं का कहना है कि सरकार घरेलू बाजार में दवा की कीमतों और बहुराष्ट्रीय दवा कंपनियों के कामकाज के संचालन के नियमन के लिए पर्याप्त प्रयास नहीं करती। सरकार द्वारा चलायी जा रही जन औषधि योजना के तहत दवा दुकानों से लोगों को उचित मूल्य पर दवा हासिल हो सके- सरकार ऐसा भी कर पाने में नाकाम रही है। <br />
<br />
बारहवीं पंचवर्षीय योजना (2013-17) में सरकारी स्वास्थ्य व्यवस्था को पुनर्जीवित करने की बात कही गई है। बहरहाल देखने वाली बात यह होगी कि क्या नीति-निर्माता लोगों की खरीद की पहुंच से बाहर जाती दवाइयों को किस हद तक उनकी पहुंच के दायरे में ला पाते हैं।&nbsp;&nbsp; &nbsp;<br />
<br />
इस कथा का विस्तार निम्नलिखित लिंक्स के सहारे किया जा सकता है- 
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
<p class="MsoNormal">
Basic backgrounders on generics and why they are lesser
priced<br />
<a href="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/" title="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/">http://health.india.com/diseases-conditions/generic-drugs-what-yo<br />
u-need-to-know/</a>
</p>
<p class="MsoNormal">
<a href="http://www.who.int/trade/glossary/story034/en/" title="http://www.who.int/trade/glossary/story034/en/">http://www.who.int/trade/glossary/story034/en/</a>
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Findings and recommendations by the government&rsquo;s High Level
Expert Group (HLEG) on Universal Health Coverage (UHC), which submitted its
report in October 2010<br />
<a href="http://uhc-india.org/reports/hleg_report_chapter_3.pdf" title="http://uhc-india.org/reports/hleg_report_chapter_3.pdf">http://uhc-india.org/reports/hleg_report_chapter_3.pdf</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
<br />
A report on meeting the challenges facing Indian pharma:&nbsp; 
</p>
<p class="MsoNormal">
<a href="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf" title="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf">http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_ph<br />
arma2902.pdf</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
The National Pharmaceutical Pricing Policy (NPPP-2012) which
was notified in November 2012 and seeks to regulate prices of 348 essential
medicines, and the Jan Aushadhi scheme for a network of public fair-price
medicine shops:
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
<a href="http://www.nppaindia.nic.in" title="http://www.nppaindia.nic.in">www.nppaindia.nic.in</a> &nbsp;<br />
<br />
<a href="http://www.janaushadhi.gov.in" title="http://www.janaushadhi.gov.in">www.janaushadhi.gov.in</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Low-cost Jan Aushadhi stores to be re-invented, The Hindu
Business Line, July 27 2012 
</p>
<p class="MsoNormal">
<a href="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece" title="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece">http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadh<br />
i-stores-to-be-reinvented/article3693097.ece</a><br />
<br />
<em><span>The implications of a failing public healthcare system for rural
Indians:</span></em>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Public health system in India has collapsed: Ramesh, The
Hindu, 16 November, 2012<br />
<a href="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece" title="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece">http://www.thehindu.com/news/national/public-health-system-in-ind<br />
ia-has-collapsed-ramesh/article4101836.ece </a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Free drugs for all?-Nirmalya Dutta, 30 November, 2012,&nbsp;
</p>
<p class="MsoNormal">
<a href="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/" title="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/">http://health.india.com/diseases-conditions/independence-day-2012<br />
-free-drugs-for-all/</a><br />
<br />
A paper exploring the links between rural indebtedness and healthcare costs in
Gurdaspur and Amritsar districts of Punjab<br />
<a href="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html" title="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html">http://www.epw.in/commentary/rural-healthcare-and-indebtedness-pu<br />
njab.html</a><br />
<br />
<em><span>Initiatives by state governments in Rajasthan and West Bengal to
provide access to affordable generic drugs:</span></em>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Mamata Banerjee battles for generic drugs, 16 March, 2012 
</p>
<p class="MsoNormal">
<a href="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/" title="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/">http://health.india.com/diseases-conditions/mamata-banerjee-battl<br />
es-for-generic-drugs/</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
India Poised to Supply Free
Drugs to 1.2 Billion People-Zofeen Ebrahim, 8 November, 2012<br />
<a href="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/" title="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/">http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-<br />
to-1-2-billion-people/</a>
</p>
<p class="MsoNormal">
There Is A
cure -Pragya Singh, Outlook, 27 July, 2009 
</p>
<p class="MsoNormal">
<a href="http://www.outlookindia.com/article.aspx?250525" title="http://www.outlookindia.com/article.aspx?250525">http://www.outlookindia.com/article.aspx?250525</a>
</p>
<p class="MsoNormal">
<br />
A field report on how the National Health Insurance system is working:<br />
<a href="http://www.who.int/bulletin/volumes/88/7/10-020710/en/" title="http://www.who.int/bulletin/volumes/88/7/10-020710/en/">http://www.who.int/bulletin/volumes/88/7/10-020710/en/</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Indian patent rulings may face legal heat internationally
-Soma Das <br />
The Economic Times, 11 April, 2013, <a href="../latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html" title="http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html">http://www.im4change.org/latest-news-updates/indian-patent-ruling<br />
s-may-face-legal-heat-internationally-soma-das-20409.html</a><br />
<br />
HIV, cancer patients seek access to affordable medicines-Aarti Dhar, <br />
<a href="../latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html" title="http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html">The
Hindu, 11 April, 2013, http://www.im4change.org/latest-news-u<br />
pdates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Natco Pharma wins cancer drug case-R Sivaraman, The Hindu, 4
March, 2013, <a href="../latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html" title="http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html">http://www.im4change.org/latest-news-updates/natco-pharma-wins-ca<br />
ncer-drug-case-r-sivaraman-19744.html </a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
EU, Australia, Canada may follow India&rsquo;s Patent Law -Divya
Rajagopal, The Economic Times, 4 April, 2013, <a href="../latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html" title="http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html">http://www.im4change.org/latest-news-updates/eu-australia-canada-<br />
may-follow-indias-patent-law-divya-rajagopal-20307.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
When innovation is under threat-Swati Piramal, The Indian
Express, 2 April, 2013, <a href="../latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html" title="http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html">http://www.im4change.org/latest-news-updates/when-innovation-is-u<br />
nder-threat-swati-piramal-20286.html</a>&nbsp; 
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
YK Sapru, founder chairperson of Cancer Patients Aid Association
(CPAA) interviewed by Sushmi Dey, The Business Standard, 3 April, 2013, <a href="../interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html" title="http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html">http://www.im4change.org/interviews/yk-sapru-founder-chairperson-<br />
of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
</div>
<div align="justify">
<span>Novartis
patent case: Glivec developer Brian Druker hails SC ruling- Chidanand
Rajghatta, The Economic Times, 3 April, 2013, <a href="../latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html">http://www.im4change.org/latest-news-updates/novartis-patent-case</a></span>
</div>
<div align="justify">
<span><a href="../latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html">-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html</a></span>
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
(एलर्ट में इस्तेमाल किए गए चित्र के लिए हम http://www.unn-edu.net/wp-content/uploads/2010/02/Medicine.jpg के आभारी हैं) <br />
</div>',
		'credit_writer' => '',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'H',
		'category_id' => (int) 70,
		'tag_keyword' => '',
		'seo_url' => 'सुप्रीम-कोर्ट-का-फैसला-और-सस्ती-दवाइयों-का-मुद्दा-5584',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 5584,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 46428,
	'metaTitle' => 'चर्चा में.... | सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा',
	'metaKeywords' => 'स्वास्थ्य,सेहत,स्वास्थ्य,सेहत',
	'metaDesc' => '
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट...',
	'disp' => '<div align="justify">
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट के फैसले के बाद एक दफे फिर से देश में यह बहस शुरु हो गई है कि सरकारी स्वास्थ्य व्यवस्था लचर है और सरकार की स्वास्थ्य नीति हर जरुरतमंद को कम कीमत में दवा उपलब्ध करा पाने में नाकाम रही है। <br />
<br />
अध्ययनों का निष्कर्ष है कि भारत में स्वास्थ्य के मद में होने वाले खर्च का 70 फीसदी हिस्सा लोगों को अपनी जेब से देना पड़ता है और इस खर्च में दवा की खरीदारी पर 50-80 फीसदी हिस्सा व्यय होता है।&nbsp; ग्रामीण विकास मंत्रालय का तो यह तक कहना है कि ग्रामीण भारतीयों के कर्ज में डूबे होने का सबसे बड़ा कारण बीमारियों के उपचार पर होने वाला खर्च है। <br />
<br />
कितनी विडंबनापूर्ण स्थिति है कि एक तरफ मरीज और उसके परिवार-जन को बीमारियों के उपचार का खर्च उठा पाना मुश्किल होता है जबकि दूसरी तरफ यह भी एक तथ्य है कि भारत का 100,000 करोड़ रुपये का दवा-उद्योग अपने आकार में विश्व में तीसरे स्थान पर है और एशिया तथा अफ्रीका के देशों में भारत की दवा-निर्माता कंपनियां सालाना 42000 करोड़ रुपये कीमत की जेनरिक(कम कीमत वाली) दवाइयां बेचती हैं।<br />
<br />
सरकार फिलहाल जीडीपी का .1 प्रतिशत(6000 करोड़ रुपये) ही दवाइयों के उपार्जन पर खर्च कर रही है। एक सरकारी रिपोर्ट में तर्क दिया गया है कि इस खर्च को बढाकर जीडीपी का 5 प्रतिशत कर दिया जाय तो &ldquo; सरकारी और निजी अभिकरणों के जरिए सबको जरुरी दवाइयां मुफ्त दी जा सकती हैं।&rdquo; <br />
<br />
इसके अतिरिक्त, अध्ययनकर्ताओं का कहना है कि सरकार घरेलू बाजार में दवा की कीमतों और बहुराष्ट्रीय दवा कंपनियों के कामकाज के संचालन के नियमन के लिए पर्याप्त प्रयास नहीं करती। सरकार द्वारा चलायी जा रही जन औषधि योजना के तहत दवा दुकानों से लोगों को उचित मूल्य पर दवा हासिल हो सके- सरकार ऐसा भी कर पाने में नाकाम रही है। <br />
<br />
बारहवीं पंचवर्षीय योजना (2013-17) में सरकारी स्वास्थ्य व्यवस्था को पुनर्जीवित करने की बात कही गई है। बहरहाल देखने वाली बात यह होगी कि क्या नीति-निर्माता लोगों की खरीद की पहुंच से बाहर जाती दवाइयों को किस हद तक उनकी पहुंच के दायरे में ला पाते हैं।&nbsp;&nbsp; &nbsp;<br />
<br />
इस कथा का विस्तार निम्नलिखित लिंक्स के सहारे किया जा सकता है- 
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
<p class="MsoNormal">
Basic backgrounders on generics and why they are lesser
priced<br />
<a href="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/" title="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/" title="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/" title="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/">http://health.india.com/diseases-conditions/generic-drugs-<br />what-yo
u-need-to-know/</a>
</p>
<p class="MsoNormal">
<a href="http://www.who.int/trade/glossary/story034/en/" title="http://www.who.int/trade/glossary/story034/en/" title="http://www.who.int/trade/glossary/story034/en/" title="http://www.who.int/trade/glossary/story034/en/">http://www.who.int/trade/glossary/story034/en/</a>
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Findings and recommendations by the government&rsquo;s High Level
Expert Group (HLEG) on Universal Health Coverage (UHC), which submitted its
report in October 2010<br />
<a href="http://uhc-india.org/reports/hleg_report_chapter_3.pdf" title="http://uhc-india.org/reports/hleg_report_chapter_3.pdf" title="http://uhc-india.org/reports/hleg_report_chapter_3.pdf" title="http://uhc-india.org/reports/hleg_report_chapter_3.pdf">http://uhc-india.org/reports/hleg_report_chapter_3.pdf</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
<br />
A report on meeting the challenges facing Indian pharma:&nbsp; 
</p>
<p class="MsoNormal">
<a href="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf" title="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf" title="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf" title="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf">http://planningcommission.nic.in/aboutus/committee/wrkgrp1<br />2/wg_ph
arma2902.pdf</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
The National Pharmaceutical Pricing Policy (NPPP-2012) which
was notified in November 2012 and seeks to regulate prices of 348 essential
medicines, and the Jan Aushadhi scheme for a network of public fair-price
medicine shops:
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
<a href="http://www.nppaindia.nic.in" title="http://www.nppaindia.nic.in" title="http://www.nppaindia.nic.in" title="http://www.nppaindia.nic.in">www.nppaindia.nic.in</a> &nbsp;<br />
<br />
<a href="http://www.janaushadhi.gov.in" title="http://www.janaushadhi.gov.in" title="http://www.janaushadhi.gov.in" title="http://www.janaushadhi.gov.in">www.janaushadhi.gov.in</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Low-cost Jan Aushadhi stores to be re-invented, The Hindu
Business Line, July 27 2012 
</p>
<p class="MsoNormal">
<a href="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece" title="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece" title="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece" title="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece">http://www.thehindubusinessline.com/marketing/lowcost-jan-<br />aushadh
i-stores-to-be-reinvented/article3693097.ece</a><br />
<br />
<em><span>The implications of a failing public healthcare system for rural
Indians:</span></em>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Public health system in India has collapsed: Ramesh, The
Hindu, 16 November, 2012<br />
<a href="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece" title="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece" title="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece" title="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece">http://www.thehindu.com/news/national/public-health-system<br />-in-ind
ia-has-collapsed-ramesh/article4101836.ece </a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Free drugs for all?-Nirmalya Dutta, 30 November, 2012,&nbsp;
</p>
<p class="MsoNormal">
<a href="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/" title="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/" title="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/" title="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/">http://health.india.com/diseases-conditions/independence-d<br />ay-2012
-free-drugs-for-all/</a><br />
<br />
A paper exploring the links between rural indebtedness and healthcare costs in
Gurdaspur and Amritsar districts of Punjab<br />
<a href="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html" title="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html" title="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html" title="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html">http://www.epw.in/commentary/rural-healthcare-and-indebted<br />ness-pu
njab.html</a><br />
<br />
<em><span>Initiatives by state governments in Rajasthan and West Bengal to
provide access to affordable generic drugs:</span></em>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Mamata Banerjee battles for generic drugs, 16 March, 2012 
</p>
<p class="MsoNormal">
<a href="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/" title="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/" title="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/" title="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/">http://health.india.com/diseases-conditions/mamata-banerje<br />e-battl
es-for-generic-drugs/</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
India Poised to Supply Free
Drugs to 1.2 Billion People-Zofeen Ebrahim, 8 November, 2012<br />
<a href="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/" title="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/" title="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/" title="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/">http://www.ipsnews.net/2012/11/india-poised-to-supply-free<br />-drugs-
to-1-2-billion-people/</a>
</p>
<p class="MsoNormal">
There Is A
cure -Pragya Singh, Outlook, 27 July, 2009 
</p>
<p class="MsoNormal">
<a href="http://www.outlookindia.com/article.aspx?250525" title="http://www.outlookindia.com/article.aspx?250525" title="http://www.outlookindia.com/article.aspx?250525" title="http://www.outlookindia.com/article.aspx?250525">http://www.outlookindia.com/article.aspx?250525</a>
</p>
<p class="MsoNormal">
<br />
A field report on how the National Health Insurance system is working:<br />
<a href="http://www.who.int/bulletin/volumes/88/7/10-020710/en/" title="http://www.who.int/bulletin/volumes/88/7/10-020710/en/" title="http://www.who.int/bulletin/volumes/88/7/10-020710/en/" title="http://www.who.int/bulletin/volumes/88/7/10-020710/en/">http://www.who.int/bulletin/volumes/88/7/10-020710/en/</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Indian patent rulings may face legal heat internationally
-Soma Das <br />
The Economic Times, 11 April, 2013, <a href="https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html" title="http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html" title="https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html" title="http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html">http://www.im4change.org/latest-news-updates/indian-patent<br />-ruling
s-may-face-legal-heat-internationally-soma-das-20<br />409.html</a><br />
<br />
HIV, cancer patients seek access to affordable medicines-Aarti Dhar, <br />
<a href="https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html" title="http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html" title="https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html" title="http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html">The
Hindu, 11 April, 2013, http://www.im4change.org/lates<br />t-news-u
pdates/hiv-cancer-patients-seek-access-to-afford<br />able-medicines-aarti-dhar-20403.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Natco Pharma wins cancer drug case-R Sivaraman, The Hindu, 4
March, 2013, <a href="https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html" title="http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html" title="https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html" title="http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html">http://www.im4change.org/latest-news-updates/natco-pharma-<br />wins-ca
ncer-drug-case-r-sivaraman-19744.html </a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
EU, Australia, Canada may follow India&rsquo;s Patent Law -Divya
Rajagopal, The Economic Times, 4 April, 2013, <a href="https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html" title="http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html" title="https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html" title="http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html">http://www.im4change.org/latest-news-updates/eu-australia-<br />canada-
may-follow-indias-patent-law-divya-rajagopal-2030<br />7.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
When innovation is under threat-Swati Piramal, The Indian
Express, 2 April, 2013, <a href="https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html" title="http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html" title="https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html" title="http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html">http://www.im4change.org/latest-news-updates/when-innovati<br />on-is-u
nder-threat-swati-piramal-20286.html</a>&nbsp; 
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
YK Sapru, founder chairperson of Cancer Patients Aid Association
(CPAA) interviewed by Sushmi Dey, The Business Standard, 3 April, 2013, <a href="https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html" title="http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html" title="https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html" title="http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html">http://www.im4change.org/interviews/yk-sapru-founder-chair<br />person-
of-cancer-patients-aid-association-cpaa-interview<br />ed-by-sushmi-dey-20267.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
</div>
<div align="justify">
<span>Novartis
patent case: Glivec developer Brian Druker hails SC ruling- Chidanand
Rajghatta, The Economic Times, 3 April, 2013, <a href="https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html">http://www.im4change.org/latest-news-updates/novartis-patent-case</a></span>
</div>
<div align="justify">
<span><a href="https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html">-glivec-developer-brian-druker-hails-sc-ruling-chidanand-r<br />ajghatta-20265.html</a></span>
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
(एलर्ट में इस्तेमाल किए गए चित्र के लिए हम http://www.unn-edu.net/wp-content/uploads/2010/02/Medicine.jpg के आभारी हैं) <br />
</div>',
	'lang' => 'Hindi',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 46428,
	'title' => 'सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा',
	'subheading' => '',
	'description' => '<div align="justify">
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट के फैसले के बाद एक दफे फिर से देश में यह बहस शुरु हो गई है कि सरकारी स्वास्थ्य व्यवस्था लचर है और सरकार की स्वास्थ्य नीति हर जरुरतमंद को कम कीमत में दवा उपलब्ध करा पाने में नाकाम रही है। <br />
<br />
अध्ययनों का निष्कर्ष है कि भारत में स्वास्थ्य के मद में होने वाले खर्च का 70 फीसदी हिस्सा लोगों को अपनी जेब से देना पड़ता है और इस खर्च में दवा की खरीदारी पर 50-80 फीसदी हिस्सा व्यय होता है।&nbsp; ग्रामीण विकास मंत्रालय का तो यह तक कहना है कि ग्रामीण भारतीयों के कर्ज में डूबे होने का सबसे बड़ा कारण बीमारियों के उपचार पर होने वाला खर्च है। <br />
<br />
कितनी विडंबनापूर्ण स्थिति है कि एक तरफ मरीज और उसके परिवार-जन को बीमारियों के उपचार का खर्च उठा पाना मुश्किल होता है जबकि दूसरी तरफ यह भी एक तथ्य है कि भारत का 100,000 करोड़ रुपये का दवा-उद्योग अपने आकार में विश्व में तीसरे स्थान पर है और एशिया तथा अफ्रीका के देशों में भारत की दवा-निर्माता कंपनियां सालाना 42000 करोड़ रुपये कीमत की जेनरिक(कम कीमत वाली) दवाइयां बेचती हैं।<br />
<br />
सरकार फिलहाल जीडीपी का .1 प्रतिशत(6000 करोड़ रुपये) ही दवाइयों के उपार्जन पर खर्च कर रही है। एक सरकारी रिपोर्ट में तर्क दिया गया है कि इस खर्च को बढाकर जीडीपी का 5 प्रतिशत कर दिया जाय तो &ldquo; सरकारी और निजी अभिकरणों के जरिए सबको जरुरी दवाइयां मुफ्त दी जा सकती हैं।&rdquo; <br />
<br />
इसके अतिरिक्त, अध्ययनकर्ताओं का कहना है कि सरकार घरेलू बाजार में दवा की कीमतों और बहुराष्ट्रीय दवा कंपनियों के कामकाज के संचालन के नियमन के लिए पर्याप्त प्रयास नहीं करती। सरकार द्वारा चलायी जा रही जन औषधि योजना के तहत दवा दुकानों से लोगों को उचित मूल्य पर दवा हासिल हो सके- सरकार ऐसा भी कर पाने में नाकाम रही है। <br />
<br />
बारहवीं पंचवर्षीय योजना (2013-17) में सरकारी स्वास्थ्य व्यवस्था को पुनर्जीवित करने की बात कही गई है। बहरहाल देखने वाली बात यह होगी कि क्या नीति-निर्माता लोगों की खरीद की पहुंच से बाहर जाती दवाइयों को किस हद तक उनकी पहुंच के दायरे में ला पाते हैं।&nbsp;&nbsp; &nbsp;<br />
<br />
इस कथा का विस्तार निम्नलिखित लिंक्स के सहारे किया जा सकता है- 
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
<p class="MsoNormal">
Basic backgrounders on generics and why they are lesser
priced<br />
<a href="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/" title="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/">http://health.india.com/diseases-conditions/generic-drugs-what-yo<br />
u-need-to-know/</a>
</p>
<p class="MsoNormal">
<a href="http://www.who.int/trade/glossary/story034/en/" title="http://www.who.int/trade/glossary/story034/en/">http://www.who.int/trade/glossary/story034/en/</a>
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Findings and recommendations by the government&rsquo;s High Level
Expert Group (HLEG) on Universal Health Coverage (UHC), which submitted its
report in October 2010<br />
<a href="http://uhc-india.org/reports/hleg_report_chapter_3.pdf" title="http://uhc-india.org/reports/hleg_report_chapter_3.pdf">http://uhc-india.org/reports/hleg_report_chapter_3.pdf</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
<br />
A report on meeting the challenges facing Indian pharma:&nbsp; 
</p>
<p class="MsoNormal">
<a href="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf" title="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf">http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_ph<br />
arma2902.pdf</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
The National Pharmaceutical Pricing Policy (NPPP-2012) which
was notified in November 2012 and seeks to regulate prices of 348 essential
medicines, and the Jan Aushadhi scheme for a network of public fair-price
medicine shops:
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
<a href="http://www.nppaindia.nic.in" title="http://www.nppaindia.nic.in">www.nppaindia.nic.in</a> &nbsp;<br />
<br />
<a href="http://www.janaushadhi.gov.in" title="http://www.janaushadhi.gov.in">www.janaushadhi.gov.in</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Low-cost Jan Aushadhi stores to be re-invented, The Hindu
Business Line, July 27 2012 
</p>
<p class="MsoNormal">
<a href="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece" title="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece">http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadh<br />
i-stores-to-be-reinvented/article3693097.ece</a><br />
<br />
<em><span>The implications of a failing public healthcare system for rural
Indians:</span></em>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Public health system in India has collapsed: Ramesh, The
Hindu, 16 November, 2012<br />
<a href="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece" title="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece">http://www.thehindu.com/news/national/public-health-system-in-ind<br />
ia-has-collapsed-ramesh/article4101836.ece </a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Free drugs for all?-Nirmalya Dutta, 30 November, 2012,&nbsp;
</p>
<p class="MsoNormal">
<a href="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/" title="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/">http://health.india.com/diseases-conditions/independence-day-2012<br />
-free-drugs-for-all/</a><br />
<br />
A paper exploring the links between rural indebtedness and healthcare costs in
Gurdaspur and Amritsar districts of Punjab<br />
<a href="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html" title="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html">http://www.epw.in/commentary/rural-healthcare-and-indebtedness-pu<br />
njab.html</a><br />
<br />
<em><span>Initiatives by state governments in Rajasthan and West Bengal to
provide access to affordable generic drugs:</span></em>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Mamata Banerjee battles for generic drugs, 16 March, 2012 
</p>
<p class="MsoNormal">
<a href="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/" title="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/">http://health.india.com/diseases-conditions/mamata-banerjee-battl<br />
es-for-generic-drugs/</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
India Poised to Supply Free
Drugs to 1.2 Billion People-Zofeen Ebrahim, 8 November, 2012<br />
<a href="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/" title="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/">http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-<br />
to-1-2-billion-people/</a>
</p>
<p class="MsoNormal">
There Is A
cure -Pragya Singh, Outlook, 27 July, 2009 
</p>
<p class="MsoNormal">
<a href="http://www.outlookindia.com/article.aspx?250525" title="http://www.outlookindia.com/article.aspx?250525">http://www.outlookindia.com/article.aspx?250525</a>
</p>
<p class="MsoNormal">
<br />
A field report on how the National Health Insurance system is working:<br />
<a href="http://www.who.int/bulletin/volumes/88/7/10-020710/en/" title="http://www.who.int/bulletin/volumes/88/7/10-020710/en/">http://www.who.int/bulletin/volumes/88/7/10-020710/en/</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Indian patent rulings may face legal heat internationally
-Soma Das <br />
The Economic Times, 11 April, 2013, <a href="../latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html" title="http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html">http://www.im4change.org/latest-news-updates/indian-patent-ruling<br />
s-may-face-legal-heat-internationally-soma-das-20409.html</a><br />
<br />
HIV, cancer patients seek access to affordable medicines-Aarti Dhar, <br />
<a href="../latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html" title="http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html">The
Hindu, 11 April, 2013, http://www.im4change.org/latest-news-u<br />
pdates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Natco Pharma wins cancer drug case-R Sivaraman, The Hindu, 4
March, 2013, <a href="../latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html" title="http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html">http://www.im4change.org/latest-news-updates/natco-pharma-wins-ca<br />
ncer-drug-case-r-sivaraman-19744.html </a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
EU, Australia, Canada may follow India&rsquo;s Patent Law -Divya
Rajagopal, The Economic Times, 4 April, 2013, <a href="../latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html" title="http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html">http://www.im4change.org/latest-news-updates/eu-australia-canada-<br />
may-follow-indias-patent-law-divya-rajagopal-20307.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
When innovation is under threat-Swati Piramal, The Indian
Express, 2 April, 2013, <a href="../latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html" title="http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html">http://www.im4change.org/latest-news-updates/when-innovation-is-u<br />
nder-threat-swati-piramal-20286.html</a>&nbsp; 
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
YK Sapru, founder chairperson of Cancer Patients Aid Association
(CPAA) interviewed by Sushmi Dey, The Business Standard, 3 April, 2013, <a href="../interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html" title="http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html">http://www.im4change.org/interviews/yk-sapru-founder-chairperson-<br />
of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
</div>
<div align="justify">
<span>Novartis
patent case: Glivec developer Brian Druker hails SC ruling- Chidanand
Rajghatta, The Economic Times, 3 April, 2013, <a href="../latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html">http://www.im4change.org/latest-news-updates/novartis-patent-case</a></span>
</div>
<div align="justify">
<span><a href="../latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html">-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html</a></span>
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
(एलर्ट में इस्तेमाल किए गए चित्र के लिए हम http://www.unn-edu.net/wp-content/uploads/2010/02/Medicine.jpg के आभारी हैं) <br />
</div>',
	'credit_writer' => '',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'H',
	'category_id' => (int) 70,
	'tag_keyword' => '',
	'seo_url' => 'सुप्रीम-कोर्ट-का-फैसला-और-सस्ती-दवाइयों-का-मुद्दा-5584',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 5584,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 46428
$metaTitle = 'चर्चा में.... | सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा'
$metaKeywords = 'स्वास्थ्य,सेहत,स्वास्थ्य,सेहत'
$metaDesc = '
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट...'
$disp = '<div align="justify">
रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट के फैसले के बाद एक दफे फिर से देश में यह बहस शुरु हो गई है कि सरकारी स्वास्थ्य व्यवस्था लचर है और सरकार की स्वास्थ्य नीति हर जरुरतमंद को कम कीमत में दवा उपलब्ध करा पाने में नाकाम रही है। <br />
<br />
अध्ययनों का निष्कर्ष है कि भारत में स्वास्थ्य के मद में होने वाले खर्च का 70 फीसदी हिस्सा लोगों को अपनी जेब से देना पड़ता है और इस खर्च में दवा की खरीदारी पर 50-80 फीसदी हिस्सा व्यय होता है।&nbsp; ग्रामीण विकास मंत्रालय का तो यह तक कहना है कि ग्रामीण भारतीयों के कर्ज में डूबे होने का सबसे बड़ा कारण बीमारियों के उपचार पर होने वाला खर्च है। <br />
<br />
कितनी विडंबनापूर्ण स्थिति है कि एक तरफ मरीज और उसके परिवार-जन को बीमारियों के उपचार का खर्च उठा पाना मुश्किल होता है जबकि दूसरी तरफ यह भी एक तथ्य है कि भारत का 100,000 करोड़ रुपये का दवा-उद्योग अपने आकार में विश्व में तीसरे स्थान पर है और एशिया तथा अफ्रीका के देशों में भारत की दवा-निर्माता कंपनियां सालाना 42000 करोड़ रुपये कीमत की जेनरिक(कम कीमत वाली) दवाइयां बेचती हैं।<br />
<br />
सरकार फिलहाल जीडीपी का .1 प्रतिशत(6000 करोड़ रुपये) ही दवाइयों के उपार्जन पर खर्च कर रही है। एक सरकारी रिपोर्ट में तर्क दिया गया है कि इस खर्च को बढाकर जीडीपी का 5 प्रतिशत कर दिया जाय तो &ldquo; सरकारी और निजी अभिकरणों के जरिए सबको जरुरी दवाइयां मुफ्त दी जा सकती हैं।&rdquo; <br />
<br />
इसके अतिरिक्त, अध्ययनकर्ताओं का कहना है कि सरकार घरेलू बाजार में दवा की कीमतों और बहुराष्ट्रीय दवा कंपनियों के कामकाज के संचालन के नियमन के लिए पर्याप्त प्रयास नहीं करती। सरकार द्वारा चलायी जा रही जन औषधि योजना के तहत दवा दुकानों से लोगों को उचित मूल्य पर दवा हासिल हो सके- सरकार ऐसा भी कर पाने में नाकाम रही है। <br />
<br />
बारहवीं पंचवर्षीय योजना (2013-17) में सरकारी स्वास्थ्य व्यवस्था को पुनर्जीवित करने की बात कही गई है। बहरहाल देखने वाली बात यह होगी कि क्या नीति-निर्माता लोगों की खरीद की पहुंच से बाहर जाती दवाइयों को किस हद तक उनकी पहुंच के दायरे में ला पाते हैं।&nbsp;&nbsp; &nbsp;<br />
<br />
इस कथा का विस्तार निम्नलिखित लिंक्स के सहारे किया जा सकता है- 
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
<p class="MsoNormal">
Basic backgrounders on generics and why they are lesser
priced<br />
<a href="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/" title="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/" title="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/" title="http://health.india.com/diseases-conditions/generic-drugs-what-you-need-to-know/">http://health.india.com/diseases-conditions/generic-drugs-<br />what-yo
u-need-to-know/</a>
</p>
<p class="MsoNormal">
<a href="http://www.who.int/trade/glossary/story034/en/" title="http://www.who.int/trade/glossary/story034/en/" title="http://www.who.int/trade/glossary/story034/en/" title="http://www.who.int/trade/glossary/story034/en/">http://www.who.int/trade/glossary/story034/en/</a>
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Findings and recommendations by the government&rsquo;s High Level
Expert Group (HLEG) on Universal Health Coverage (UHC), which submitted its
report in October 2010<br />
<a href="http://uhc-india.org/reports/hleg_report_chapter_3.pdf" title="http://uhc-india.org/reports/hleg_report_chapter_3.pdf" title="http://uhc-india.org/reports/hleg_report_chapter_3.pdf" title="http://uhc-india.org/reports/hleg_report_chapter_3.pdf">http://uhc-india.org/reports/hleg_report_chapter_3.pdf</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
<br />
A report on meeting the challenges facing Indian pharma:&nbsp; 
</p>
<p class="MsoNormal">
<a href="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf" title="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf" title="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf" title="http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf">http://planningcommission.nic.in/aboutus/committee/wrkgrp1<br />2/wg_ph
arma2902.pdf</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
The National Pharmaceutical Pricing Policy (NPPP-2012) which
was notified in November 2012 and seeks to regulate prices of 348 essential
medicines, and the Jan Aushadhi scheme for a network of public fair-price
medicine shops:
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
<a href="http://www.nppaindia.nic.in" title="http://www.nppaindia.nic.in" title="http://www.nppaindia.nic.in" title="http://www.nppaindia.nic.in">www.nppaindia.nic.in</a> &nbsp;<br />
<br />
<a href="http://www.janaushadhi.gov.in" title="http://www.janaushadhi.gov.in" title="http://www.janaushadhi.gov.in" title="http://www.janaushadhi.gov.in">www.janaushadhi.gov.in</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Low-cost Jan Aushadhi stores to be re-invented, The Hindu
Business Line, July 27 2012 
</p>
<p class="MsoNormal">
<a href="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece" title="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece" title="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece" title="http://www.thehindubusinessline.com/marketing/lowcost-jan-aushadhi-stores-to-be-reinvented/article3693097.ece">http://www.thehindubusinessline.com/marketing/lowcost-jan-<br />aushadh
i-stores-to-be-reinvented/article3693097.ece</a><br />
<br />
<em><span>The implications of a failing public healthcare system for rural
Indians:</span></em>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Public health system in India has collapsed: Ramesh, The
Hindu, 16 November, 2012<br />
<a href="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece" title="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece" title="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece" title="http://www.thehindu.com/news/national/public-health-system-in-india-has-collapsed-ramesh/article4101836.ece">http://www.thehindu.com/news/national/public-health-system<br />-in-ind
ia-has-collapsed-ramesh/article4101836.ece </a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Free drugs for all?-Nirmalya Dutta, 30 November, 2012,&nbsp;
</p>
<p class="MsoNormal">
<a href="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/" title="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/" title="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/" title="http://health.india.com/diseases-conditions/independence-day-2012-free-drugs-for-all/">http://health.india.com/diseases-conditions/independence-d<br />ay-2012
-free-drugs-for-all/</a><br />
<br />
A paper exploring the links between rural indebtedness and healthcare costs in
Gurdaspur and Amritsar districts of Punjab<br />
<a href="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html" title="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html" title="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html" title="http://www.epw.in/commentary/rural-healthcare-and-indebtedness-punjab.html">http://www.epw.in/commentary/rural-healthcare-and-indebted<br />ness-pu
njab.html</a><br />
<br />
<em><span>Initiatives by state governments in Rajasthan and West Bengal to
provide access to affordable generic drugs:</span></em>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Mamata Banerjee battles for generic drugs, 16 March, 2012 
</p>
<p class="MsoNormal">
<a href="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/" title="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/" title="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/" title="http://health.india.com/diseases-conditions/mamata-banerjee-battles-for-generic-drugs/">http://health.india.com/diseases-conditions/mamata-banerje<br />e-battl
es-for-generic-drugs/</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
India Poised to Supply Free
Drugs to 1.2 Billion People-Zofeen Ebrahim, 8 November, 2012<br />
<a href="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/" title="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/" title="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/" title="http://www.ipsnews.net/2012/11/india-poised-to-supply-free-drugs-to-1-2-billion-people/">http://www.ipsnews.net/2012/11/india-poised-to-supply-free<br />-drugs-
to-1-2-billion-people/</a>
</p>
<p class="MsoNormal">
There Is A
cure -Pragya Singh, Outlook, 27 July, 2009 
</p>
<p class="MsoNormal">
<a href="http://www.outlookindia.com/article.aspx?250525" title="http://www.outlookindia.com/article.aspx?250525" title="http://www.outlookindia.com/article.aspx?250525" title="http://www.outlookindia.com/article.aspx?250525">http://www.outlookindia.com/article.aspx?250525</a>
</p>
<p class="MsoNormal">
<br />
A field report on how the National Health Insurance system is working:<br />
<a href="http://www.who.int/bulletin/volumes/88/7/10-020710/en/" title="http://www.who.int/bulletin/volumes/88/7/10-020710/en/" title="http://www.who.int/bulletin/volumes/88/7/10-020710/en/" title="http://www.who.int/bulletin/volumes/88/7/10-020710/en/">http://www.who.int/bulletin/volumes/88/7/10-020710/en/</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Indian patent rulings may face legal heat internationally
-Soma Das <br />
The Economic Times, 11 April, 2013, <a href="https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html" title="http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html" title="https://im4change.in/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html" title="http://www.im4change.org/latest-news-updates/indian-patent-rulings-may-face-legal-heat-internationally-soma-das-20409.html">http://www.im4change.org/latest-news-updates/indian-patent<br />-ruling
s-may-face-legal-heat-internationally-soma-das-20<br />409.html</a><br />
<br />
HIV, cancer patients seek access to affordable medicines-Aarti Dhar, <br />
<a href="https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html" title="http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html" title="https://im4change.in/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html" title="http://www.im4change.org/latest-news-updates/hiv-cancer-patients-seek-access-to-affordable-medicines-aarti-dhar-20403.html">The
Hindu, 11 April, 2013, http://www.im4change.org/lates<br />t-news-u
pdates/hiv-cancer-patients-seek-access-to-afford<br />able-medicines-aarti-dhar-20403.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
Natco Pharma wins cancer drug case-R Sivaraman, The Hindu, 4
March, 2013, <a href="https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html" title="http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html" title="https://im4change.in/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html" title="http://www.im4change.org/latest-news-updates/natco-pharma-wins-cancer-drug-case-r-sivaraman-19744.html">http://www.im4change.org/latest-news-updates/natco-pharma-<br />wins-ca
ncer-drug-case-r-sivaraman-19744.html </a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
EU, Australia, Canada may follow India&rsquo;s Patent Law -Divya
Rajagopal, The Economic Times, 4 April, 2013, <a href="https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html" title="http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html" title="https://im4change.in/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html" title="http://www.im4change.org/latest-news-updates/eu-australia-canada-may-follow-indias-patent-law-divya-rajagopal-20307.html">http://www.im4change.org/latest-news-updates/eu-australia-<br />canada-
may-follow-indias-patent-law-divya-rajagopal-2030<br />7.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
When innovation is under threat-Swati Piramal, The Indian
Express, 2 April, 2013, <a href="https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html" title="http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html" title="https://im4change.in/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html" title="http://www.im4change.org/latest-news-updates/when-innovation-is-under-threat-swati-piramal-20286.html">http://www.im4change.org/latest-news-updates/when-innovati<br />on-is-u
nder-threat-swati-piramal-20286.html</a>&nbsp; 
</p>
<p class="MsoNormal">
&nbsp;
</p>
<p class="MsoNormal">
YK Sapru, founder chairperson of Cancer Patients Aid Association
(CPAA) interviewed by Sushmi Dey, The Business Standard, 3 April, 2013, <a href="https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html" title="http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html" title="https://im4change.in/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html" title="http://www.im4change.org/interviews/yk-sapru-founder-chairperson-of-cancer-patients-aid-association-cpaa-interviewed-by-sushmi-dey-20267.html">http://www.im4change.org/interviews/yk-sapru-founder-chair<br />person-
of-cancer-patients-aid-association-cpaa-interview<br />ed-by-sushmi-dey-20267.html</a>
</p>
<p class="MsoNormal">
&nbsp;
</p>
</div>
<div align="justify">
<span>Novartis
patent case: Glivec developer Brian Druker hails SC ruling- Chidanand
Rajghatta, The Economic Times, 3 April, 2013, <a href="https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html">http://www.im4change.org/latest-news-updates/novartis-patent-case</a></span>
</div>
<div align="justify">
<span><a href="https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="https://im4change.in/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html" title="http://www.im4change.org/latest-news-updates/novartis-patent-case-glivec-developer-brian-druker-hails-sc-ruling-chidanand-rajghatta-20265.html">-glivec-developer-brian-druker-hails-sc-ruling-chidanand-r<br />ajghatta-20265.html</a></span>
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
(एलर्ट में इस्तेमाल किए गए चित्र के लिए हम http://www.unn-edu.net/wp-content/uploads/2010/02/Medicine.jpg के आभारी हैं) <br />
</div>'
$lang = 'Hindi'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

सुप्रीम कोर्ट का फैसला और सस्ती दवाइयों का मुद्दा

रक्त-कैंसर रोधी महंगी और पुरस्कार प्राप्त दवा ग्लीवेक से जुड़े पेंटेंट अधिकार की भारत में रक्षा की जाय- दवा बनाने वाली मशहूर नोवार्टिस कंपनी ने यह गुहार लगायी थी लेकिन सुप्रीम कोर्ट ने अपने फैसले में इसे खारिज कर दिया।कोर्ट के फैसले के बाद एक दफे फिर से देश में यह बहस शुरु हो गई है कि सरकारी स्वास्थ्य व्यवस्था लचर है और सरकार की स्वास्थ्य नीति हर जरुरतमंद को कम कीमत में दवा उपलब्ध करा पाने में नाकाम रही है। अध्ययनों का निष्कर्ष है कि भारत में स्वास्थ्य के मद में होने वाले खर्च का 70 फीसदी हिस्सा लोगों को अपनी जेब से देना पड़ता है और इस खर्च में दवा की खरीदारी पर 50-80 फीसदी हिस्सा व्यय होता है।  ग्रामीण विकास मंत्रालय का तो यह तक कहना है कि ग्रामीण भारतीयों के कर्ज में डूबे होने का सबसे बड़ा कारण बीमारियों के उपचार पर होने वाला खर्च है। कितनी विडंबनापूर्ण स्थिति है कि एक तरफ मरीज और उसके परिवार-जन को बीमारियों के उपचार का खर्च उठा पाना मुश्किल होता है जबकि दूसरी तरफ यह भी एक तथ्य है कि भारत का 100,000 करोड़ रुपये का दवा-उद्योग अपने आकार में विश्व में तीसरे स्थान पर है और एशिया तथा अफ्रीका के देशों में भारत की दवा-निर्माता कंपनियां सालाना 42000 करोड़ रुपये कीमत की जेनरिक(कम कीमत वाली) दवाइयां बेचती हैं। सरकार फिलहाल जीडीपी का .1 प्रतिशत(6000 करोड़ रुपये) ही दवाइयों के उपार्जन पर खर्च कर रही है। एक सरकारी रिपोर्ट में तर्क दिया गया है कि इस खर्च को बढाकर जीडीपी का 5 प्रतिशत कर दिया जाय तो “ सरकारी और निजी अभिकरणों के जरिए सबको जरुरी दवाइयां मुफ्त दी जा सकती हैं।” इसके अतिरिक्त, अध्ययनकर्ताओं का कहना है कि सरकार घरेलू बाजार में दवा की कीमतों और बहुराष्ट्रीय दवा कंपनियों के कामकाज के संचालन के नियमन के लिए पर्याप्त प्रयास नहीं करती। सरकार द्वारा चलायी जा रही जन औषधि योजना के तहत दवा दुकानों से लोगों को उचित मूल्य पर दवा हासिल हो सके- सरकार ऐसा भी कर पाने में नाकाम रही है। बारहवीं पंचवर्षीय योजना (2013-17) में सरकारी स्वास्थ्य व्यवस्था को पुनर्जीवित करने की बात कही गई है। बहरहाल देखने वाली बात यह होगी कि क्या नीति-निर्माता लोगों की खरीद की पहुंच से बाहर जाती दवाइयों को किस हद तक उनकी पहुंच के दायरे में ला पाते हैं।     इस कथा का विस्तार निम्नलिखित लिंक्स के सहारे किया जा सकता है-   Basic backgrounders on generics and why they are lesser priced http://health.india.com/diseases-conditions/generic-drugs- what-yo u-need-to-know/ http://www.who.int/trade/glossary/story034/en/       Findings and recommendations by the government’s High Level Expert Group (HLEG) on Universal Health Coverage (UHC), which submitted its report in October 2010 http://uhc-india.org/reports/hleg_report_chapter_3.pdf   A report on meeting the challenges facing Indian pharma:  http://planningcommission.nic.in/aboutus/committee/wrkgrp1 2/wg_ph arma2902.pdf     The National Pharmaceutical Pricing Policy (NPPP-2012) which was notified in November 2012 and seeks to regulate prices of 348 essential medicines, and the Jan Aushadhi scheme for a network of public fair-price medicine shops:   www.nppaindia.nic.in   www.janaushadhi.gov.in   Low-cost Jan Aushadhi stores to be re-invented, The Hindu Business Line, July 27 2012 http://www.thehindubusinessline.com/marketing/lowcost-jan- aushadh i-stores-to-be-reinvented/article3693097.ece The implications of a failing public healthcare system for rural Indians:   Public health system in India has collapsed: Ramesh, The Hindu, 16 November, 2012 http://www.thehindu.com/news/national/public-health-system -in-ind ia-has-collapsed-ramesh/article4101836.ece     Free drugs for all?-Nirmalya Dutta, 30 November, 2012,  http://health.india.com/diseases-conditions/independence-d ay-2012 -free-drugs-for-all/ A paper exploring the links between rural indebtedness and healthcare costs in Gurdaspur and Amritsar districts of Punjab http://www.epw.in/commentary/rural-healthcare-and-indebted ness-pu njab.html Initiatives by state governments in Rajasthan and West Bengal to provide access to affordable generic drugs:   Mamata Banerjee battles for generic drugs, 16 March, 2012 http://health.india.com/diseases-conditions/mamata-banerje e-battl es-for-generic-drugs/   India Poised to Supply Free Drugs to 1.2 Billion People-Zofeen Ebrahim, 8 November, 2012 http://www.ipsnews.net/2012/11/india-poised-to-supply-free -drugs- to-1-2-billion-people/ There Is A cure -Pragya Singh, Outlook, 27 July, 2009 http://www.outlookindia.com/article.aspx?250525 A field report on how the National Health Insurance system is working: http://www.who.int/bulletin/volumes/88/7/10-020710/en/   Indian patent rulings may face legal heat internationally -Soma Das The Economic Times, 11 April, 2013, http://www.im4change.org/latest-news-updates/indian-patent -ruling s-may-face-legal-heat-internationally-soma-das-20 409.html HIV, cancer patients seek access to affordable medicines-Aarti Dhar, The Hindu, 11 April, 2013, http://www.im4change.org/lates t-news-u pdates/hiv-cancer-patients-seek-access-to-afford able-medicines-aarti-dhar-20403.html   Natco Pharma wins cancer drug case-R Sivaraman, The Hindu, 4 March, 2013, http://www.im4change.org/latest-news-updates/natco-pharma- wins-ca ncer-drug-case-r-sivaraman-19744.html   EU, Australia, Canada may follow India’s Patent Law -Divya Rajagopal, The Economic Times, 4 April, 2013, http://www.im4change.org/latest-news-updates/eu-australia- canada- may-follow-indias-patent-law-divya-rajagopal-2030 7.html   When innovation is under threat-Swati Piramal, The Indian Express, 2 April, 2013, http://www.im4change.org/latest-news-updates/when-innovati on-is-u nder-threat-swati-piramal-20286.html    YK Sapru, founder chairperson of Cancer Patients Aid Association (CPAA) interviewed by Sushmi Dey, The Business Standard, 3 April, 2013, http://www.im4change.org/interviews/yk-sapru-founder-chair person- of-cancer-patients-aid-association-cpaa-interview ed-by-sushmi-dey-20267.html   Novartis patent case: Glivec developer Brian Druker hails SC ruling- Chidanand Rajghatta, The Economic Times, 3 April, 2013, http://www.im4change.org/latest-news-updates/novartis-patent-case -glivec-developer-brian-druker-hails-sc-ruling-chidanand-r ajghatta-20265.html   (एलर्ट में इस्तेमाल किए गए चित्र के लिए हम http://www.unn-edu.net/wp-content/uploads/2010/02/Medicine.jpg के आभारी हैं)